怷扟 戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂旝彮怹弫娻偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
CANCET BOARD of the BREAST 2018;4(1):27-28.
怷扟 戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂傾億僋儕儞娻偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
CANCET BOARD of the BREAST 2018;4(1):25-26.
悪嶳 桾巕, 嵅乆栘 姲, 彫徏 嫗巕, 摗嶳 弤嶰, 桏壓 棾巌, 忋栰 婌嶰榊, 彫揷 悙宐, 栴擺 尋擇, 怉揷 惌巏, 揷楬 塸嶌, 斅帩 峀柧, 戝愇 揙榊, 墱愳 奭, 壛摗 惞巕, 摗揷 攷惓, 揷忋 柅, 揷惃 嫓, 斞尨 媣恗巕, 忋朧 晀巕, 楅栘 夒巕, 嶰戭 恀巌, 戝捤 廳懃, 敥嶳 廳弔, 怷扟 戩栫
巕媨栩晹嵶朎恌惛搙娗棟偵偍偗傞帺摦僗僋儕乕僯儞僌巟墖僔僗僥儉偺桳梡惈偵偮偄偰
擔椪嵶朎帍丂2018;57(Suppl.1):19-34.
Hazama Y, Moriya T, Sugihara M, Sano R, Shiota M, Nakamura T, Shimoya K.
The Analysis of Cell Cycle-related Proteins in Ovarian Clear Cell Carcinoma Versus High-grade Serous Carcinoma.
Int J Gynecol Pathol. 2017;[Epub ahead of print]
Sano R, Kanomata N, Suzuki S, Shimoya K, Sato Y, Moriya T, Shiota M.
Vasohibin-1 Is a Poor Prognostic Factor of Ovarian Carcinoma.
Tohoku J Exp Med. 2017;243(2):107-114.
Arata Y, Tanabe K, Hinamoto N, Yamasaki H, Sugiyama H, Maeshima Y, Kanomata N, Sato Y, Wada J.
Immunohistochemistry of Vasohibin-2 in Human Kidney Disease : Implications in Impaired Glucose Tolerance and Reduced Renal Function.
Acta Med Okayama. 2017;71(5):369-380.
Kanomata N, Matsuura S, Nomura T, Kurebayashi J, Mori T, Kitawaki J, Moriya T.
Preparation of a novel antiserum to aromatase with high affinity and specificity: Its clinicopathological significance on breast cancer tissue.
PLoS One. 2017;12(5):e0177439.
Hattori K, Maeda T, Nishida S, Imanishi M, Sakaguchi M, Amari Y, Moriya T, Hirose Y.
Correlation of lanthanum dosage with lanthanum deposition in the gastroduodenal mucosa of dialysis patients.
Pathol Int. 2017;67(9):447-452.
Ohta Y,Koike Y, Saitoh W, Yamashita T,Tanaka K, Kanomata N, Moriya T, Kurebayashi J.
Anti-cancer stem cell activity of the Src丂inhibitor丂dasatinib in thyroid cancer cells.
Kawasaki Medical Journal. 2017;43(2):63-78.
Sasaki Y, Iwanari O, Arakawa I, Moriya T, Mikami Y, Iihara K, Konno R.
Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan.
Int J Gynecol Cancer. 2017;27(3):523-529.
Koike Y, Ohta Y, Saitoh W, Yamashita T, Kanomata N, Moriya T, Kurebayashi J.
Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells.
Breast Cancer. 2017;24(5):683-693.
Kurebayashi J, Koike Y, Ohta Y, Saitoh W, Yamashita T, Kanomata N, Moriya T.
Anti-cancer stem cell activity of a hedgehog inhibitor GANT61 in estrogen receptor-positive breast cancer cells.
Cancer Sci. 2017;108(5):918-930.
Kido A, Tamada T, Sone T, Kanomata N, Miyaji Y, Yamamoto A, Ito K.
Incremental value of high b value diffusion-weighted magnetic resonance imaging at 3-T for prediction of extracapsular extension in patients with prostate cancer: preliminary experience.
Radiol Med. 2017;122(3):228-238.
Nakayama K, Yagata H, Hayashi N, Yoshida A, Takei J, Moriya T, Suzuki K, Yamauchi H.
Breast cancer with an extremely high Ki-67 labeling index despite a low nuclear grade.
Pathol Int. 2017;67(2):118-120.
怷扟 戩栫
亂擕娻僎僲儉堛椕嵟慜慄-椪彴墳梡偼偳偙傑偱恑傫偩偐亃 Ki67
CURRENT THERAPY. 2017;35(9):883-887.
怷扟 戩栫,嵅娧 巎柧
亂揮堏惈愐捙庮釃偵懳偡傞嵟彫怤廝愐捙埨掕弍(MISt)亃 昦棟堛偐傜傒偨揮堏惈愐捙庮釃偺恌抐
惍宍奜壢嵟彫怤廝庤弍僕儍乕僫儖 2017;87:2-7.
幁屢 捈庽
怴恡丒斿擜婍娻丂恡娻偺専嵏丒恌抐丆昦棟恌抐丂恡庮釃偺昦棟慻怐妛揑暘椶
擔杮椪喱 2017;75(憹姧崋6):203-206.
怷扟 戩栫,嵅娧 巎柧
傛偔傢偐傞昦棟恌抐曬崘彂丂僾儘僎僗僥儘儞庴梕懱専嶕偺堄媊偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
CANCET BOARD of the BREAST 2017;3(2):30-31.
怷扟 戩栫,嵅娧 巎柧
傛偔傢偐傞昦棟恌抐曬崘彂丂TIL偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
CANCET BOARD of the BREAST 2017;3(2):28-29.
幁屢 捈庽,嵅娧 巎柧,堫媑 婱奊,埶岝 戝桽,怷扟 戩栫
CPC夝愢(戞95夞)丂帺慠曵夡宆庮釃曵夡徢岓孮傪偒偨偟偨怘摴娻徢椺偺堦朥専椺
昦棟偲椪彴 2017;35(6):561-566.
怷扟 戩栫
擕娻恌椕偵偍偗傞僨僕僞儖僷僜儘僕乕偺堄媊
擕娻偺椪彴 2017;32(3):215-222.
怷扟 戩栫丆幁屢 捈庽丆堫媑 婱奊,
擕娻妛丂擕娻偺徢岓偲専嵏丆恌抐 Ki-67
擔杮椪喱 2017;75(憹姧崋3):242-246.
怷扟 戩栫
亂昦棟恌抐偵捈寢偟偨慻怐妛亃 擕態
昦棟偲椪彴 2017;35(椪帪憹姧崋):12-20.
怷扟 戩栫
擕娻偵懳偡傞Ki-67儔儀儕儞僌僀儞僨僢僋僗寁應丂尰忬偲壽戣
昦棟偲椪彴 2017;35(3):286-287.
怷扟 戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂Claudin-low宆偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
CANCET BOARD of the BREAST 2017;3(1):26-27.
怷扟 戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂Neuroendocrine carcinoma偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
CANCET BOARD of the BREAST 2017;3(1):28-29.
怷扟 戩栫
昦棟堛偲擕偑傫
僺儞僋儕儃儞NEWS 2017;6(1):1-6.
嶳杮 桾, 峠椦 弤堦丆嶰忋 崉巌丆娸栰 塴旤丆悰尨 幀怐丆彫憅 堦宐丆嶳杮 惓棙丆釼摗 榠丆懢揷 桾夘丆彫抮 椙榓丆嶳壓 揘惓丆栰懞 挿媣丆揷拞 崕峗丆幁屢 捈庽丆怷扟 戩栫
僙儞僠僱儖儕儞僷愡惗専傪巤峴偟偨泓鈢儕儞僷愡旝彫揮堏擕娻徢椺偺専摙
愳嶈堛妛夛帍 2017;43(1):1-7.
怷扟 戩栫,堫媑 婱奊,幁屢 捈庽
儂儖儌儞偵娭偡傞彈惈偺偑傫丗擕偑傫偺偡傋偰擕偑傫恌抐偵偍偗傞嵶朎恌偲慻怐恌偺栤戣揰
HORMONE FRONTIER IN GYNECOLOGY. 2017;24(1):23-26.
Morita M, Yamaguchi R, Tanaka M, Tse GM, Yamaguchi M, Otsuka H, Kanomata N, Minami S, Eguchi S, Yano H.
Two progressive pathways of microinvasive carcinoma: low-grade luminal pathway and high-grade HER2 pathway based on high tumour-infiltrating lymphocytes.
J Clin Pathol. 2016;69(10):890-8.
Sugiyama Y, Sasaki H, Komatsu K, Yabushita R, Oda M, Yanoh K, Ueda M, Itamochi H, Okugawa K, Fujita H, Tase T, Nakatani E, Moriya T.
A Multi-Institutional Feasibility Study on the Use of Automated Screening Systems for Quality Control Rescreening of Cervical Cytology.
Acta Cytol. 2016;60(5):451-457.
Kanematsu M, Morimoto M, Takahashi M, Honda J, Bando Y, Moriya T, Tadokoro Y, Nakagawa M, Takechi H, Yoshida T, Toba H, Yoshida M, Kajikawa A, Tangoku A, Imoto I, Sasa M.
Thirty percent of ductal carcinoma in situ of the breast in Japan is extremely low-grade ER(+)/HER2(-) type without comedo necrosis.
J Med Invest. 2016;63(3-4):192-8.
Morita M, Yamaguchi R, Tanaka M, Tse GM, Yamaguchi M, Kanomata N, Naito Y, Akiba J, Hattori S, Minami S, Eguchi S, Yano H.
CD8(+) tumor-infiltrating lymphocytes contribute to spontaneous "healing" in HER2-positive ductal carcinoma in situ.
Cancer Med. 2016;5(7):1607-18.
Moriya T.
The current topics of surgical pathology of breast cancer in Japan.
Breast Cancer. 2016;23(4):533.
Sano R, Suzuki S, Moriya T, Shiota M.
Disseminated peritoneal leiomyomatosis incidentally discovered during laparoscopic surgery.
GMIT. 2016;6(1):38-39.
Shibata H, Kato S, Sekine I, Abe K, Araki N, Iguchi H, Izumi T, Inaba Y, Osaka I, Kato S, Kawai A, Kinuya S, Kodaira M, Kobayashi E, Kobayashi T, Sato J, Shinohara N, Takahashi S, Takamatsu Y, Takayama K, Takayama K, Tateishi U, Nagakura H, Hosaka M, Morioka H, Moriya T, Yuasa T, Yurikusa T, Yomiya K, Yoshida M.
Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology.
ESMO Open. 2016;1(2):e000037.
Leung S, Nielsen TO, Zabaglo L, Arun I, Badve SS, Bane AL, Bartlett JM, Borgquist S, Chang MC, Dodson A, Enos RA, Fineberg S, Focke CM, Gao D, Gown AM, Grabau D, Gutierrez C, Hugh JC, Kos Z, Lankholm AV, Lin MG, Mastropasqua MG, Moriya T, Nofech-Mozes S, Osborne CK, Penault-Llorca FM, Piper T, Sakatani T, Salgado R, Starczynski J, Viale G, Hayes DF, McShane LM, Dowsett M.
Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration.
npj Breast Cancer. 2016;(2):16014.
Matsuo K, Takazawa Y, Ross MS, Elishaev E, Podzielinski I, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Matsuzaki S, Baba T, Satoh S, Shida M, Nishikawa T, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Fujiwara K, Hazama Y, Kadogami D, Moffitt MN, Takeuchi S, Nishimura M, Iwasaki K, Ushioda N, Johnson MS, Yoshida M, Hakam A, Li SW, Richmond AM, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Yamaguchi K, Oishi T, Kajiwara H, Hasegawa K, Yasuda M, Kawana K, Suda K, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Wakatsuki A, Sugiyama T, Pejovic T, Nagano T, Shimoya K, Andoh M, Shiki Y, Enomoto T, Sasaki T, Fujiwara K, Mikami M, Shimada M, Konishi I, Kimura T, Post MD, Shahzad MM, Im DD, Yoshida H, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD.
Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma.
Ann Oncol. 2016;27(7):1257-66.
Tanaka S, Kanomata N, Teramura K, Wakita K, Kunihisa T, Yano Y, Moriya T, Hayashi Y.
Usefulness of immunocytochemistry using a Breast Marker antibody cocktail targeting P63/cytokeratin7/18/cytokeratin5/14 for fine needle aspiration of the breast: a retrospective cohort study of 139 cases.
Cytopathology. 2016;27(6):465-471.
Ishida K, Sasano H, Moriya T, Takahashi Y1,, Sugimoto R, Mue Y, Murakami K, Fujishima F, Nakamura Y, Morikawa T, Motoi F, Suzuki T, Unno M, Sugai T.
Immunohistochemical analysis of steroidogenic enzymes in ovarian-type stroma of pancreatic mucinous cystic neoplasms: Comparative study of subepithelial stromal cells in intraductal papillary mucinous neoplasms of the pancreas.
Pathol Int. 2016;66(5):281-7.
Tamada T, Sone T, Kanomata N, Miyaji Y, Kido A, Jo Y, Yamamoto A, Ito K.
Value of preoperative 3T multiparametric MRI for surgical margin status in patients with prostate cancer.
J Magn Reson Imaging. 2016;44(3):584-93.
怷扟 戩栫,堫媑 婱奊,幁屢捈庽
亂晈恖壢埆惈庮釃婯栺夵掶偺億僀儞僩偲懳墳-乽壗偑乿乽側偤乿乽偳偺傛偆偵乿曄傢偭偨偺偐亃丂巕媨栩晹昦曄 WHO 2014擭 巕媨栩晹昦曄偺夵掶偺億僀儞僩
椪彴晈恖壢嶻壢 2016;70(8):686-690.
怷扟 戩栫, 堫媑 婱奊
傛偔傢偐傞昦棟恌抐曬崘彂丂擲塼傪嶻惗偡傞擕態昦曄偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
CANCET BOARD of the BREAST 2016;2(2)28-29.
怷扟 戩栫, 堫媑 婱奊
傛偔傢偐傞昦棟恌抐曬崘彂丂壔惗娻(WHO)偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
CANCET BOARD of the BREAST 2016;2(2)30-31.
怷扟 戩栫, 堫媑 婱奊, 幁屢 捈庽
WHO 2014擭 巕媨栩晹昦曄偺夵掶偺億僀儞僩
椪彴晈恖壢嶻壢 2016;70(8)686-689.
怷扟 戩栫, 堫媑 婱奊, 幁屢 捈庽
亂旕怹弫惈擕娗娻(DCIS)偺恌抐偲帯椕亃 擕態旕怹弫娻偺昦棟
奜壢 2016;78(7):690-694.
怷扟 戩栫
儊僨傿僇儖僀儔僗僩儗乕僔儑儞
昦棟偲椪彴 2016;34(3):310-311.
怷扟 戩栫, 堫媑婱奊
傛偔傢偐傞昦棟恌抐曬崘彂丂曻幩忬峝壔惈昦曄偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
CANCET BOARD of the BREAST 2016;2(1):32-34.
怷扟 戩栫, 埳摗偟偘傒
傛偔傢偐傞昦棟恌抐曬崘彂丂HER2偺CLSH朄丆DISH朄偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
CANCET BOARD of the BREAST 2016;2(1):29-31.
怷扟 戩栫, 楅栘 憦堦榊, 幁屢 捈庽
擕娻偺僎僲儉堎忢偲昦棟慻怐憸
娻偲壔妛椕朄 2016;43(3):290-293.
Tamada T, Ito K, Kanomata N, Sone T, Kanki A, Higaki A, Hayashida M, Yamamoto A.
Pancreatic adenocarcinomas without secondary signs on multiphasic multidetector CT: association with clinical and histopathologic features.
Eur Radiol. 2016;26(3):646-655.
Kurebayashi J, Kanomata N, Yamashita T, Shimo T, Mizutoh A, Moriya T, Sonoo H.
Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Breast cancer. 2015;22(3):292-299.
Tanaka R, Inagawa K, Kanomata N, Hata J, Fujimoto W.
Photoletter to the editor: Pigmented dermatofibrosarcoma protuberans in a 4-year-old girl and ultrasonographic findings.
J Dermatol Case Rep. 2015;9(2):52-54.
Mizutou A, Nakashima K, Moriya T.
Large pseudoangiomatous stromal hyperplasia complicated with gynecomastia and lobular differentiation in a male breast.
Springerplus. 2015;19(4):282.
Polley MY, Leung SC, Gao D, Mastropasqua MG, Zabaglo LA, Bartlett JM, McShane LM, Enos RA, Badve SS, Bane AL, Borgquist S, Fineberg S, Lin MG, Gown AM, Grabau D9, Gutierrez C, Hugh JC, Moriya T, Ohi Y, Osborne CK, Penault-Llorca FM, Piper T, Porter PL, Sakatani T, Salgado R, Starczynski J, Lankholm AV, Viale G, Dowsett M, Hayes DF, Nielsen TO.
An international study to increase concordance in Ki67 scoring.
Mod Pathol. 2015;28(6):778-786.
Ueno D, Nakashima H, Higashida M, Yoshida K, Hino K, Irei I, Moriya T, Matsumoto H, Hirai T, Nakamura M.
Emergent laparoscopic cholecystectomy for acute acalculous cholecystitis revisited.
Surg Today. 2015;46(3):309-312.
Morimoto M, Bando Y, Nakagawa M, Takechi H, Yoshida T, Honda J, Tadokoro Y, Moriya T, Sasa M, Tangoku A.
Immunocytochemical results for HER2 and Ki67 in breast cancer touch-smear cell specimens are reliable.
Breast Cancer. 2015;23(4):577-82.
Moriya T, Hirakawa H, Nagashima M, Yasuda M, Kimijima I.
IgG4-related disease of the breast: a systemic disease whose mammary manifestations mimic breast cancer.
Int Canc Conf J. 2015;4(2):67-72.
Hida A, Bando K, Sugita A, Maeda T, Ueda N, Matsukage S, Nakanishi M, Kito K, Miyazaki T, Ohtsuki Y, Oshiro Y, Inoue H, Kawaguchi H, Yamashita N, Aogi K, Moriya T.
Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility.
J Clin Pathol. 2015;68(5):356-361.
Kurebayashi J, Kanomata N, Yamashita T, Shimo T, Moriya T.
Antitumor and anticancer stem cell activities of eribulin mesylate and antiestrogens in breast cancer cells.
Breast Cancer. 2015;23(3):425-36.
暷 椇桽, 幁屢 捈庽, 暉壆 旤撧巕, 鑓尨 戱梇, 怷扟 戩栫
擕態嵶朎恌専懱偵偍偗傞CK5/14+p63+CK7/18僇僋僥儖峈懱偵傛傞懡廳愼怓偺婎慴揑専摙
擔杮椪彴嵶朎妛夛嶨帍 2015;54(2):170-171.
怷扟 戩栫
亂傛偔傢偐傞専嵏偲恌抐亃 (戞2復)晈恖壢庮釃暘栰丂巕媨懱娻丂巕媨撪枌慻怐恌
嶻壢偲晈恖壢 2015;82(Suppl.):174-177.
怷扟 戩栫, 暉壆 旤撧巕, 暷 椇桟, 挿搱 恀婭, 幁屢 捈庽
亂慂巋媧堷嵶朎恌偺尒曽偲恌抐偦偟偰嵟怴偺抦尒-嵶朎憸偲慻怐憸傪懳斾偟偰-亃 擕態丂椙惈/嫬奅昦曄
昦棟偲椪彴 2015;33(11):1193-1198.
摗堜 惔崄, 捙栘 帬梇, 墍旜 攷巌, 怷扟 戩栫
壓巿帀朾怐墛傪敽偭偨擏夎庮惈擕態墛偺1椺
擔杮椪彴奜壢妛夛嶨帍 2015;76(11):2640-2644.
塇娫 梉婭巕,暉壠丂怣擇,悪尨 栱崄, 嵅栰 椡嵠, 懞揷 戩栫, 拞堜 桽堦榊, 拞懞 棽暥,墫揷 廩, 怷扟 戩栫,壓壆 峗堦榊
拞婜拞愨屻偵弌寣惈僔儑僢僋傪棃偟宱暊挻壒攇僇儔乕僪僾儔朄偵偰戀斦億儕乕僾傪媈偭偨徢椺
尰戙嶻晈恖壢 2015;64(1):85-90.
庤搰 怢堦,怷扟 戩栫
亂棏憙庮釃I-昦棟偺怴偟偄峫偊偐偨-亃 棏憙庮釃偺怴WHO暘椶
昦棟偲椪彴 2015;33(9):932-937.
怷扟 戩栫,楅栘 憦堦榊,嵅栰 椡嵠,墫揷 廩
亂棏憙庮釃I-昦棟偺怴偟偄峫偊偐偨-亃 柧嵶朎庮釃
昦棟偲椪彴 2015;33(9):955-960.
怷扟 戩栫,丂楅栘 憦堦榊
傛偔傢偐傞昦棟恌抐曬崘彂丂St Gallen 2015偺昦棟妛揑側曄峏揰偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
CANCET BOARD of the BREAST 2015;1(2):32-33.
怷扟 戩栫,丂楅栘 憦堦榊
傛偔傢偐傞昦棟恌抐曬崘彂丂擕摢忬昦曄偺椙埆惈敾掕偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
CANCET BOARD of the BREAST 2015;1(2):29-31.
壨悾 抭嵠, 媑揷 峗巌, 晉嶳 嫳峴, 恗壢 憏帯, 尨 桾堦, 怷扟 戩栫, 拞懞 夒巎, 擔栰 孾曘
捠忢宆鋁娻恑揥偵偍偗傞Fibroblast activation protein 兛敪尰偵娭偡傞椪彴昦棟妛揑専摙
愳嶈堛妛夛帍 2015;41(1):9-17.
怷扟 戩栫, 楅栘 徍旻
Ki-67偲偼(Q&A)
擔杮堛帠怴曬 2015;4754:62.
怷扟 戩栫, 楅栘 徍旻
擕娻専恌偵偍偗傞夁忚恌抐偵懳偡傞昦棟妛偐傜偺峫偊曽(Q&A)
擔杮堛帠怴曬 2015;4753:59.
怷扟 戩栫
巕媨撪枌慻怐恌
嶻壢偲晈恖壢 傛偔傢偐傞専嵏偲恌抐 2015;82(憹姧崋):174-177.
暷椇桽, 幁屢 捈庽, 暉壆 旤撧巕,鑓尨 戱梇, 怷扟 戩栫
擕態嵶朎恌専懱偵偍偗傞CK5/14+p63+CK7/18僇僋僥儖峈懱偵傛傞懡廳愼怓偺婎慴専摙
擔杮椪彴嵶朎妛夛嶨帍 2015;54(2):170-171.
怷扟 戩栫,丂摗堜 惔崄
傛偔傢偐傞昦棟恌抐曬崘彂丂EIC乮extensive intraductal components乯偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
CANCER BOARD of the BREAST 2015;1(1):34-35.
怷扟 戩栫,丂摗堜 惔崄
傛偔傢偐傞昦棟恌抐曬崘彂丂恓惗専偵偍偗傞擕娻埆惈搙昡壙偺惛搙偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
CANCER BOARD of the BREAST 2015;1(1):32-33.
愳栰椇丆戝昹庻攷丆怷扟 戩栫
10噊埲壓偺擕態庮釒偵懳偡傞Real-time Tissue Elastography 偺桳梡惈
擕態峛忬態挻壒攇堛妛 2015;4(1):1-7.
Matsuo Y, Tashiro H, Yanai H, Moriya T, Katabuchi H.
Clinicopathological heterogeneity in ovarian clear cell adenocarcinoma: a study on individual therapy practice.
Med Mol Morphol. 2014;48(3):146-154.
Niikura N, Sakatani T, Arima N, Ohi Y, Honma N, Kanomata N, Yoshida K, Kadoya T, Tamaki K, Kumaki N, Iwamoto T, Sugie T, Moriya T.
Assessment of the Ki67 labeling index: a Japanese validation ring study.
Breast Cancer. 2014;23(1):92-100.
Kurebayashi J, Kanomata N, Shimo T, Yamashita T, Aogi K, Nishimura R, Shimizu C, Tsuda H, Moriya T, Sonoo H.
Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone.
Breast Cancer. 2014;21(2):214-22.
Hayano T, Yokota Y, Hosomichi K, Nakaoka H, Yoshihara K, Adachi S, Kashima K, Tsuda H, Moriya T, Tanaka K, Enomoto T, Inoue I.
Molecular characterization of an intact p53 pathway subtype in high-grade serous ovarian cancer.
PLoS One. 2014;9(12):e114491.
Ito T, Sato N, Yamaguchi Y, Tazawa C, Moriya T, Hirakawa H, Hayashi SI.
Differences in Stemness Properties Associated With the Heterogeneity of Luminal-Type Breast Cancer.
Clin Breast Cancer. 2014;15(2):e93-103.
Matsuo Y, Tashiro H, Yanai H, Moriya T, Katabuchi H.
Clinicopathological heterogeneity in ovarian clear cell adenocarcinoma: a study on individual therapy practice.
Med Mol Morphol. 2014;48(3):146-154.
Yamaguchi R, Tanaka M, Tse GM, Yamaguchi M, Terasaki H, Hirai Y, Nonaka Y, Morita M, Yokoyama T, Kanomata N, Naito Y, Akiba J, Yano H.
Management of breast papillary lesions diagnosed at ultrasound-guided vacuum-assisted and core needle biopsies.
Histopathology. 2014;66(4):565-76.
Kanomata N, Ochiai A.
TP53 mutations of intestinal metaplasia.
Hum Pathol. 2014;45(2):431.
Hinamoto N, Maeshima Y, Saito D, Yamasaki H, Tanabe K, Nasu T, Watatani H, Ujike H, Kinomura M, Sugiyama H, Sonoda H, Kanomata N, Sato Y, Makino H.
Renal distribution of Vasohibin-1 in patients with chronic kidney disease.
Acta Med Okayama. 2014;68(4):219-33.
Tamada T, Kanomata N, Sone T, Jo Y, Miyaji Y, Higashi H, Yamamoto A, Ito K.
High b value (2,000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla: comparison with 1,000 s/mm2 for tumor conspicuity and discrimination of aggressiveness.
PLoS ONE. 2014;9(5):e96619.
Shimo T, Kurebayashi J, Kanomata N, Yamashita T, Kozuka Y, Moriya T, Sonoo H.
Antitumor and anticancer stem cell activity of a poly ADP-ribose polymerase inhibitor olaparib in breast cancer cells.
Breast Cancer. 2014;21(1):75-85.
彫椦 峕棙, 峳栘 朙巕, 暷 椇桽, 鑓尨 戱梇, 廐嶳 棽, 幁屢 捈庽, 怷扟 戩栫
埆惈儕儞僷庮偲娪暿崲擄偱偁偭偨擕朳撪儕儞僷愡偺1椺
壀嶳導椪彴嵶朎妛夛帍 2014;33:19-22.
棝 愥攡, 怷扟 戩栫, 鑓尨 戱梇
忋奀寬峃怑嬈媄弍妛堾偲愳嶈堛椕抁婜戝妛偺椪彴専嵏壢偵偍偗傞昦棟専嵏媄弍嫵堢偺斾妑
愳嶈堛椕抁婜戝妛婭梫 2014;34:9-12.
幁屢捈庽, 怷扟戩栫
抦偭偰偄傞偲栶棫偮斿擜婍昦棟 徢椺:40戙丒抝惈
椪彴斿擜婍壢 2014;68(13):991-994.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂揮堏惈娻昦憙偵偍偗傞丄擕態尨敪偺悇掕偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
Cancer Board 擕娻 2014;7(2):132-133.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂僷僕僃僢僩昦偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
Cancer Board 擕娻 2014;7(2):134-135.
摗堜惔崄, 捙栘帬梇, 墍旜攷巌, 幁屢捈庽, 怷扟戩栫
崪丒擃崪惉暘偲娻惉暘傪敽偆埆惈梩忬庮釃偺1椺
擔杮椪彴奜壢妛夛嶨帍 2014;75(11):2982-2985.
嶳壓揘惓丆峠椦弤堦丆釼摗榠丆彫抮椙榓丆懢揷桾夘丆壓搊巙楴丆嶳杮桾丆揷拞崕峗丆幁屢捈庽丆怷扟戩栫
僙儞僠僱儖儕儞僷愡惗専傪巤峴偟偨抝惈擕娻偺侾椺
擕娻偺椪彴 2014;29(4):369-373.
敥擇榊丆廐嶳棽丆怷扟戩栫
徚壔娗丂媫惈拵悅墛乮夡醩惈乯丂80嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):1148-1151.
敥擇榊丆廐嶳棽丆怷扟戩栫
徚壔娗丂夞栍晹MALT儕儞僷庮丂60嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):1145-1147.
敥擇榊丆廐嶳棽丆怷扟戩栫
徚壔娗丂僗僉儖僗堓娻丂30嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):1142-1144.
敥擇榊丆廐嶳棽丆怷扟戩栫
徚壔娗丂憗婜堓娻丂60嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):1139-1141.
敥擇榊丆廐嶳棽丆怷扟戩栫
娞抇鋁銪丂庡鋁娗宆鋁娗撪擕摢擲塼惈庮釃丂80嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):1120-1122.
怷扟戩栫丆嶳杮桾丆拞搰堦婤
擕態丂擕態慄堐徢丂70嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):971-973.
怷扟戩栫丆嶳杮桾丆拞搰堦婤
擕態丂怹弫惈彫梩娻丂50嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):968-970.
怷扟戩栫丆嶳杮桾丆拞搰堦婤
擕態丂擕態埆惈儕儞僷庮丂50嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):966-967.
怷扟戩栫丆拞搰堦婤
擕態丂擕態梩忬庮釃丂50嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):963-965.
怷扟戩栫丆拞搰堦婤
擕態丂娗忬娻丂50嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):961-962.
怷扟戩栫丆拞搰堦婤
擕態丂擕娗撪擕摢庮丂70嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):958-960.
怷扟戩栫丆拞愳旤柤巕丆拞搰堦婤
擕態丂旕怹弫惈擕娗娻丂40嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):955-957.
怷扟戩栫丆幁屢捈庽丆拞搰堦婤
擕態丂擕摢態娗娻丂30嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):952-954.
怷扟戩栫丆拞搰堦婤
擕態丂梓棻嵶朎庮丂60嵨戙抝惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):949-951.
怷扟戩栫丆暯愳媣丆拞搰堦婤
擕態丂態嬝忋旂庮丂50嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):946-948.
怷扟戩栫丆拞搰堦婤
擕態丂擲塼娻丂40嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):943-945.
怷扟戩栫丆拞搰堦婤
擕態丂怹弫惈旝彫擕摢娻丂50嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):940-942.
怷扟戩栫丆拞搰堦婤
擕態丂曻幩忬峝壔惈昦曄丂70嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):937-939.
怷扟戩栫丆拞搰堦婤
擕態丂擕態慄堐態庮丂30嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):934-936.
怷扟戩栫丆拞搰堦婤
擕態丂怹弫惈擕娗娻乮廩幚態娗娻乯丂60嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):931-933.
怷扟戩栫丆拞搰堦婤
擕態丂怹弫惈擕娗娻乮峝娻乯丂50嵨戙彈惈
専嵏偲媄弍 挻壒攇亊昦棟 懳斾傾僩儔僗 2014;42(10 憹姧崋):928-930.
媨嶈埢巕丆攡杮夒旻丆嵅栰椡嵠丆怷扟戩栫丆墫揷廩
僷僂僠撪儌儖僙儗乕僔儑儞朄傪梡偄偨暊峯嬀壓巕媨嬝庮妀弌弍拞偺慻怐曅旘嶶杊巭偺岺晇乕Apoplectic leiomyoma偲恌抐偝傟偨堦椺乕
擔杮嶻壢晈恖壢撪帇嬀妛夛嶨帍 2014;30(1):280-285.
怷扟戩栫丆幁屢捈庽
亂擕娻偺塽妛丒専恌丒恌抐2014乣2016亃 ER丄PgR丄HER2丄Ki-67偺昡壙
僐儞僙儞僒僗娻帯椕 2014;13(3):148-152.
摗堜惔崄, 揷拞崕峗, 懢揷桾夘, 彫抮椙榓, 嶳壓揘惓, 壓搊巙楴, 悈摗徎巕, 嶳杮桾, 捙栘帬梇, 峠椦弤堦, 墍旜攷巌, 幁屢捈庽, 怷扟戩栫
寣惔CA19-9堎忢崅抣偵偰敪尒偝傟偨峛忬態擕摢娻偺1椺
擔杮撪暘斿丒峛忬態奜壢妛夛嶨帍 2014;31(2):154-157.
怷扟戩栫丆幁屢捈庽
僩僺僢僋僗丗庮釃昦棟恌抐偺up to date(1)擕娻
椪彴昦棟 2014;62(6):560-567.
敥災, 暉壆旤撧巕, 幁屢捈庽, 怷扟戩栫
亂塼忬壔専懱嵶朎恌(LBC)偵偼偳傫側儊儕僢僩偑偁傞偐亃 擕態慂巋媧堷嵶朎恌偵偍偗傞廬棃朄偲LBC朄偺嵶朎偺尒曽丂棙揰側傜傃偵栤戣揰偵偮偄偰
椪彴専嵏 2014;58(6):685-692.
怷扟戩栫丆嶳杮 桾
擕態慄堐徢(恾愢)
専嵏偲媄弍 2014;42(6):553.
怷扟戩栫
亂椪彴丒夋憸丒昦棟僩儔僀傾儞僌儖亃丂彈惈惗怋婍姶愼徢 亀彈惈惗怋婍姶愼徢亁昦棟偺棫応偐傜
塮憸忣曬Medical 2014;46(5):435-436.
怷扟戩栫
亂巕媨栩偑傫恌椕偵偍偗傞嵟怴偺榖戣亃 巕媨栩晹偺昦棟丂嵟怴偺榖戣
嫗晎堛戝帍 2014;123(5):325-331.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂怹弫惈旝彫擕摢娻偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
Cancer Board 擕娻 2014;7(1):40-41.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂擕朳撪偺愇奃壔偺庬椶偲堄媊偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
Cancer Board 擕娻 2014;7(1):38-39.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂怹弫丒婾怹弫偺敾掕朄偲堄媊偵偮偄偰嫵偊偰壓偝偄(Q&A)
Cancer Board 擕娻 2014;6(2):38-39.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂弍拞恦懍昦棟恌抐偺惛搙娗棟偵偮偄偰嫵偊偰壓偝偄(Q&A)
Cancer Board 擕娻 2014;6(2):36-37.
Sawai T, Uzuki M, Miura Y, Kamataki A, Matsumura T, Saito K, Kurose A, Osamura YR, Yoshimi N, Kanno H, Moriya T, Ishida Y, Satoh Y, Nakao M, Ogawa E, Matsuo S, Kasai H, Kumagai K, Motoda T, Hopson N.
World's first telepathology experiments employing WINDS ultra-high-speed internet satellite, nicknamed "KIZUNA".
J Pathol Inform. 2013;4:24.
Tsukamoto N, Egawa S, Akada M, Abe K, Saiki Y, Kaneko N, Yokoyama S, Shima K, Yamamura A, Motoi F, Abe H, Hayashi H, Ishida K, Moriya T, Tabata T, Kondo E, Kanai N, Gu Z, Sunamura M, Unno M, Horii A.
The Expression of S100A4 in Human Pancreatic Cancer Is Associated With Invasion.
Pancreas. 2013;42(6):1027-33.
Kanomata N, Hasebe T, Moriya T, Ochiai A.
Simultaneous demonstration of gelatinolytic activity, morphology, and immunohistochemical reaction using zymography film.
Med Mol Morphol. 2013;46(4):193-197.
Kanomata N, Sato Y, Miyaji Y, Nagai A, Moriya T.
Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma.
J Clin Pathol. 2013;66(7):613-619.
Hida A, Oshiro Y, Inoue H, Kawaguchi H, Yamashita N, Moriya T.
Visual assessment of Ki67 at a glance is an easy method to exclude many luminal-type breast cancers from counting 1000 cells.
Breast Cancer. 2013;22(2):129-34.
Korenaga K, Korenaga M, Teramoto F, Suzuki T, Nishina S, Sasaki K, Nakashima Y, Tomiyama Y, Yoshioka N, Hara Y, Moriya T, Hino K.
Clinical usefulness of non-protein respiratory quotient measurement in non-alcoholic fatty liver disease.
Hepatol Res. 2013;43(12):1284-1294.
Kimijima I, Yoshida K, Tamura R, Moriya T.
Effectiveness of multi-detector row computed tomography in detection of the presence and extent of ductal carcinoma in situ.
Breast Cancer. 2013;20(1):26-33.
彫椦 峕棙,峳栘 朙巕,暷 椇桽,鑓尨 戱梇,敥 災, 埳釾 岟,幁屢 捈庽,怷扟 戩栫
10嵨戙屻敿偵敪惗偟偨擜枌娗娻偺1椺
擔杮椪彴嵶朎妛夛壀嶳導巟晹夛帍 2013;32:21-25.
嶳壓揘惓,峠椦弤堦,幁屢捈庽,壓搊巙楴,怷扟戩栫,墍旜攷巌
僄僗僩儘僎儞庴梕懱梲惈擕娻嵶朎偵偍偗傞峈僄僗僩儘僎儞栻偲 mTOR 慾奞栻僄儀儘儕儉僗偺嵶朎憹怋媦傃 娻姴嵶朎惂屼偵懳偡傞岠壥
愳嶈堛妛夛帍 2013;39(3):65-79.
抮揷惇庽丆旜挿扟桋,戝怉徦峅丄惉晊恀棟丆怷扟戩栫丆壀嶰婌抝
弍屻23擭偱嬊強嵞敪傪擣傔偢懡敪攛揮堏偱敪寯偝傟偨悜枌旂惈悜枌庮偺1椺
擔杮屇媧婍妛夛帍 2013;2(6):832-835.
怷扟戩栫丆崱懞岲復丆愹旤婱丆戝搰岶堦丆崟悾尠丆敧旜棽巎
昦棟恌抐僐儞僒儖僥乕僔儑儞偺尰忬丂擔杮昦棟妛夛僐儞僒儖僥乕僔儑儞僔僗僥儉偺尰忬偲彨棃憸
昦棟偲椪彴 2013;31(12):1278-1283.
怷扟戩栫,嶳杮桾
怹弫惈彫梩娻
専嵏偲媄弍 2013;42(3):231.
怷扟戩栫,嶳杮桾
擕態埆惈儕儞僷庮
専嵏偲媄弍 2013;41(13):1231.
怷扟戩栫, 幁屢 捈庽
亂擕態庮釃up to date:WHO暘椶夵掶偺梫揰II亃 椙埆惈娪暿偺億僀儞僩丂擕摢忬昦曄丂擕娗撪擕摢忬昦曄
昦棟偲椪彴 2013;31(10):1076-1082.
怷扟戩栫丆奆栘弮巕, 恗壢岾巕,鑓尨宐巕,嶁杮桼旤,嬥巕椣嫵,抾懞桼晍崄,捸堜桾巕,屆愳 揟巕,恀撶崕屓,拞懞怣旻,怉栘岹柧
徚壔偲偼乗堛妛偺棫応偐傜乗
棟壢嫵幒 2013;56(9):32-37.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂暯扲宆堎宆偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
Cancer Board 擕娻 2013;6(1):52-53.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂嫻丒暊悈偺昦棟専嵏偵偍偗傞僙儖僽儘僢僋朄偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
Cancer Board 擕娻 2013;6(1):50-51.
怷扟戩栫丆挿搱恀婭
亂嵶朎恌偺婎杮偐傜幚慔傊亃 (戞2晹)嵶朎恌偺幚嵺偲僩僺僢僋僗丂擕態丂椙惈乣嫬奅昦曄
昦棟偲椪彴 2013;31(椪憹):275-282.
幁屢 捈庽, 怷扟 戩栫
抦偭偰偄傞偲栶棫偮斿擜婍昦棟 徢椺:60戙丒彈惈
椪彴斿擜婍壢 2013;67(1):3-6.
Okubo S, Kurebayashi J, Sonoo H, Yamashita T, Kanomata N, Moriya T.
Two cases of spindle cell carcinoma of the breast - Usefulness of immunohistochemical analysis.
Kawasaki Medical Journal. 2012;38(1):33-39.
Takahashi M, Furukawa Y, Shimodaira H, Sakayori M, Moriya T, Moriya Y, Nakamura Y, Ishioka C.
Aberrant splicing caused by a MLH1 splice donor site mutation found in a young Japanese patient with Lynch syndrome.
Fam Cancer. 2012;11(4):559-64.
Yamaguchi R, Tanaka M, Yano A, Tse GM, Yamaguchi M, Koura K, Kanomata N, Kawaguchi A, Akiba J, Naito Y, Ohshima K, Yano H.
Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer.
Hum Pathol. 2012;43(10):1688-94.
Takagi K, Moriya T, Kurosumi M, Oka K, Miki Y, Ebata A, Toshima T, Tsunekawa S, Takei H, Hirakawa H, Ishida T, Hayashi S, Kurebayashi J, Sasano H, Suzuki T.
Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma.
Horm Cancer. 2012;4(1):1-11.
Takahashi Y, Koyanagi T, Suzuki Y, Saga Y, Kanomata N, Moriya T, Suzuki M, Sato Y.
Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
Mol Cancer Res. 2012;10(9):1135-46.
Kanomata N
Neuroendocrine and mucinous differentiation in signet ring cell carcinoma of the stomach: evidence for a common cell of origin in composite tumors.
Hum Pathol. 2012;43(8):1344.
Yanoh K, Hirai Y, Sakamoto A, Aoki D, Moriya T, Hiura M, Yamawaki T, Shimizu K, Nakayama H, Sasaki H, Tabata T, Ueda M, Udagawa Y, Norimatsu Y.
New terminology for intrauterine endometrial samples: a group study by the Japanese Society of Clinical Cytology.
Acta Cytol. 2012;56(3):233-41.
Nakashima K, Moriya T.
Comprehensive ultrasound diagnosis for intraductal spread of primary breast cancer.
Breast Cancer. 2012;20:3-12.
Yoshihara K, Tsunoda T, Shigemizu D, Fujiwara H, Hatae M, Fujiwara H, Masuzaki H, Katabuchi H, Kawakami Y, Okamoto A, Nogawa T, Matsumura N, Udagawa Y, Saito T, Itamochi H, Takano M, Miyagi E, Sudo T, Ushijima K, Iwase H, Seki H, Terao Y, Enomoto T, Mikami M, Akazawa K, Tsuda H, Moriya T, Tajima A, Inoue I, Tanaka K.
High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by down-regulation of antigen presentation pathway.
Clin Cancer Res. 2012;18(5):1374-1385.
Kaku S, Moriya T, Ushioda N, Nakai Y, Shimoya K, Nakamura T.
A case of serous endometrial intraepithelial carcinoma with p53 positivity for six years.
The Journal of Obstetrics and Gynaecology Research. 2012;38(2):455-460.
Nakagawa M, Bando Y, Nagao T, Takai C, Ohnishi T, Honda J, Moriya T, Izumi K, Takahashi M, Tangoku A, Sasa M.
Among triple-negative breast cancers, HER2(0) breast cancer shows a strong tendency to be basal-like compared with HER2(1+) breast cancer: preliminary results.
Breast Cancer. 2012;19(1):54-59
峳栘朙巕, 幁屢捈庽, 暉壆旤撧巕, 鑓尨戱梇, 敥災, 廐嶳棽, 郷嶈廃師, 掕暯媑搒
嵍慜嫻晹旂壓庮釒偺慂巋媧堷嵶朎恌偱恌抐偑崲擄偱偁偭偨擃崪擏庮偺堦椺
擔杮椪彴嵶朎妛夛壀嶳導巟晹夛帍 2012,31:29-33.
恄夑 婱戝, 埨惣 椙堦, 扥栰 峅峎, 怷扟 戩栫, 奀栰 椣柧
堓宔幒撪堓娻傪崌暪偟偨惉恖堓婏宍庮偺1椺
擔徚奜夛帍 2012;45(12):1161-1169.
怷扟戩栫丆幁屢捈庽丆彫捤桽巌丆峠椦弤堦
擕偑傫偺昦棟恌抐偵偍偗傞儗僋僠儞愼怓偺桳梡惈
悪嶳嶻嬈壔妛尋媶強擭曬 2012;23(1):56-62.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂昦棟妛揑側庮釃宎偺寁應偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
Cancer Board 擕娻 2012;5(2):140-141.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂梩忬庮釃偺昦棟妛揑埆惈搙昡壙偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
Cancer Board 擕娻 2012;5(2):142-143.
嶳娸 抭巕, 惔悈 崕旻, 拞揷 徆抝, 媨抧 掯岾, 塱堜 撝, 幁屢 捈庽, 怷扟 戩栫
攛揮堏憙偵偍偄偰Growing Teratoma Syndrome傪掓偟偨惛憙尨敪泱嵶朎庮釃偺1椺
娻偲壔妛椕朄 2012;39(10):1579-1581.
怷扟戩栫
巕媨偑傫専恌偲嵶朎恌丂嵟嬤偺摦岦
擔杮椪彴嵶朎妛夛廐揷導巟晹夛帍 2012;16:20-28.
怷扟戩栫
埆惈偲娫堘偄傗偡偄椙惈擕態幘姵偺昦棟偲嵶朎憸
擔杮椪彴嵶朎妛夛杒奀摴巟晹夛曬 2012;18:1-3.
怷扟戩栫, 拞搰 堦婤
娗忬娻
専嵏偲媄弍 2012;40(9):830.
怷扟 戩栫丆幁屢捈庽
亂擕娻(戞2斉)-婎慴偲椪彴偺嵟怴尋媶摦岦-亃 擕娻偺専嵏丒恌抐丂擕娻偺昦棟専嵏丒恌抐丂擕娻偺昦棟儗億乕僩偺婎杮偲愗彍昗杮偺庢埖偄
擔杮椪彴 2012;70(憹姧7 擕娻):385-390.
崱懞 桽巙, 懞旜 崅媣, 徏杮 孾巙, 悅悈 尋堦, 崃晹 婭柧, 嶳壓 捈恖, 幁屢 捈庽, 廐嶳 棽, 敥 擇榊, 弔娫 尗
儕儞僷愡揮堏傪棃偨偟偨宎1cm枹枮偺堓恄宱撪暘斿庮釃偺1椺
Gastroenterol Endosc. 2012;54(8):2219-2224.
怷扟戩栫, 拞搰 堦婤
擕娗撪擕摢庮
専嵏偲媄弍 2012;40(6):497.
悈摗 徎巕, 墍旜 攷巌, 釼摗 榠, 彫抮 椙榓, 嶳壓 揘惓, 摗堜 惔崄, 壓 搊巙楴, 嶳杮 桾, 捙栘 帬梇, 拞搰 堦婤, 揷拞 崕峗, 峠椦 弤堦, 怷扟 戩栫
摉壢偵偍偗傞擕娻徢椺偺弍慜昦棟恌抐偺専摙
愳嶈堛妛夛帍 2012;38(1):1-10.
摗尨 塸悽, 郷嶈 廃師, 幁屢 捈庽, 徏嶈 榓恗, 惣懞 峀寬, 埳釾 岟, 廐嶳 棽, 掕暯 媑搒
Rossete-forming glioneuronal tumor偺1椺
恌抐昦棟 2012;29(2):136-141.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂St.Gallen 2011偵偍偗傞昦棟娭楢偺夵掕揰偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
Cancer Board 擕娻 2012;5(1):44-45.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂怹弫惈擕娻偵偍偗傞Ki-67偺専嶕堄媊偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
Cancer Board 擕娻 2012;5(1):46-47.
徏旜 桬帣, 媨尨 梲, 杮揷 棩惗, 戝抾 廏岾, 揷戙 峗摽, 桍堜 峀擵, 怷扟 戩栫, 曅熀 廏棽
棏憙柧嵶朎態娻Ia婜偵懳偡傞昦棟慻怐妛揑娤揰偐傜偺峫嶡
擔杮晈恖壢庮釃妛夛嶨帍 2012;30(2):129-134.
嶚壀弐曘, 徏旜柧巕, 揷拞椆, 杚栰塸堦, 懢揷抦巕, 廐嶳攷怢, 忢媊惌, 怷扟戩栫, 摗杮榡
儕儞僷愡妔惔屻偵in-transit揮堏昦憙偑懡敪偟偨堿宻埆惈崟怓庮
Skin Cancer. 2012;26(3):342乚347.
怷扟戩栫, 拞愳旤柤巕
旕怹弫惈擕娗娻
専嵏偲媄弍丂2012;40(1):40.
怷扟戩栫丆幁屢捈庽
巕媨懱娻偺昦棟恌抐偵娭偡傞嵟嬤偺僩僺僢僋僗
嶻壢偲晈恖壢丂2012;2(7):125-130.
Nakagawa M, Bando Y, Nagao T, Morimoto M, Takai C, Ohnishi T, Honda J, Moriya T, Izumi K, Takahashi M, Sasa M, Tangoku A.
Expression of p53, Ki-67, E-Cadherin, N-Cadherin and TOP2A in Triple-negative Breast Cancer.
Anticancer Res. 2011;31(6):2389-93.
Hata T, Irei I, Moriya T, Hosoda M.
Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates therapy: diagnostic value of the detached-hypernucleated osteoclasts -A preliminary report.
Asian J Ora Maxillofac Surg丏2011;23丗59-62.
Ohtani S, Kochi M, Ito M, Higaki K, Takada S, Matsuura H, Kagawa N, Hata S, Wada N, Inai K, Imoto S, Moriya T.
Radiofrequency ablation of early breast cancer followed by delayed surgical resection - A promising alternative to breast-conserving surgery.
Breast. 2011;20(5):431-436.
Takami K, Moriya T, Kamiga T, Abe T, Miseki T, Oku T, Aoki Y, Tominaga T.
Adenocarcinoma of the minor duodenal papilla: report of a case.
Case Rep Gastroenterol. 2011;13(5):1.
Chan S-K, Lui P C W, Tan P-H, Yamaguchi R, Moriya T, Yu A M C, Shao M-M, Hliang T, Wong S-I & Tse G M.
Increased alpha-B-crystallin expression in mammary metaplastic carcinomas.
Histopathology. 2011;59:247-255.
Doi N, Tomiyama Y, Kawase T, Nishina S, Yoshioka N, Hara Y, Yoshida K, Korenaga K, Korenaga M, Moriya T, Urakami A, Nakashima O, Kojiro M, Hino K.
Focal Nodular Hyperplasia - Like Nodule with Reduced Expression of Organic Anion Transporter 1B3 in Alcohbolic Liver Cirrhosis.
Internal Medicine. 2011;50:1193-1199.
Kurebayashi J, Kanomata N, Kozuka Y, Moriya T, Kikukawa N, Kawasaki Y, Harada S, Tamura S, Nakayama S, Ishihara H, Noguchi S, Sonoo H.
The cell cycle profile (C2P) test is a prognostic indicator for breast cancer patients treated with postoperative 5-fluorouracil-based chemotherapy.
Jpn J Clin Oncol. 2011;41(6):739-746.
Kanomata N, Kurebayashi J, Kozuka Y, Sonoo H, Moriya T.
Clinicopathological significance of Y416Src and Y527Src expression in breast cancer.
J Clin Pathol. 2011;64(7):578-586.
Kaku S, Moriya T, Kanomata N, Ishida T, ChangYangsil, Ushioda N, Nakai Y, Shimoya K丆Nakamura T
A case of extremely rare ovarian tumor: Primary ovarian adenomyoma.
Kawasaki Medical Journal. 2011;37(4):233-237.
Tamada T, Sone T, Miyaji Y, Kozuka Y, Ito K.
MRI appearance of prostatic stromal sarcoma in a young adult.
Korean J Radiol. 2011;12(4):519-523.
Hayashizaki Y, Usui K, Moriya T, Hashiyada M, Usui A, Hosokai Y, Kawasumi Y, Saito H, Funayama M.
Unexpected infant death due to hypoplastic left heart syndrome: A case report.
Leg Med (Tokyo). 2011;13(6):293-297.
Sakai Y, Ohbayashi C, Kanomata N, Kajimoto K, Sakuma T, Maniwa Y, Nishio W, Tauchi S, Uchino K, Yoshimura M
Significance of microscopic invasion into hilar peribronchovascular soft tissue in resection specimens of primary non-small cell lung cancer.
Lung Cancer. 2011;73(1):89-95.
Kuroda N, Kanomata N, Yamaguchi T, Imamura Y, Ohe C, Sakaida N, Hes O, Michal M, Shuin T, Lee GH.
Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma.
Med Mol Morphol. 2011;44(2);111-115.
Kanomata N, Kozuka Y, Moriya T.
Prostatic intraepithelial pagetoid histiocyte: a potential diagnostic pitfall.
Pathology International. 2011;61(9):551.
Fujishima F, Suzuki T, Nakamura Y, Taniyama Y, Ono K, Sugawara A, Miyazaki S, Moriya T, Sato A, Satomi S, Sasano H.
Retinoid receptors in human esophageal squamous cell carcinoma: retinoid X receptor as a potent prognostic factor.
Pathol Int. 2011;61(7):401-408.
Kawasaki T, Oyama T, Nakagomi H, Furuya K, Kondo T, Nakazawa T, Mochizuki K, Yamane T, Miyazawa T, Ishii Y, Fukushima K, Moriya T, Tsunoda H, Katoh R.
Massive myoepithelial proliferation (myoepitheliosis) with lumpy deposits of basement membrane material closely associated with apocrine adenosis and ductal carcinoma in situ of the breast.
Pathol Int. 2011;61(10):615-617.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂怹弫惈彫梩娻偵偮偄偰嫵偊偰壓偝偄
Cancer Board 擕娻丂2011;4(2):52-53.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂堎宆擕娗夁宍惉乮ADH乯偵偮偄偰嫵偊偰壓偝偄
Cancer Board 擕娻丂2011;4(2):50-51.
怷扟戩栫丆幁屢捈庽丆 拞搰堦婤
擕態擕摢態娗娻
専嵏偲媄弍丂2011;39(9):671.
怷扟戩栫, 拞搰堦婤
擕態梓棻嵶朎庮
専嵏偲媄弍丂2011;39(5):364.
怷扟戩栫, 幁屢捈庽, 彫捤桽巌
旕怹弫惈擕娗娻偍傛傃擕娗撪昦曄偺昦棟恌抐丂嵟嬤偺榖戣傕娷傔偰
恌抐昦棟丂2011;28(2):79-89.
峠椦弤堦, 幁屢捈庽
擕娻偺愇奃壔昦憙偺敪惗婡彉(Q&A)
擔杮堛帠怴曬丂2011;4542:56-57.
怷扟戩栫, 幁屢捈庽, 彫捤桽巌丆怷扟楅巕丆摗尨寜
巕媨撪枌憹怋徢丒椶撪枌態娻偲偺娪暿傪梫偡傞巕媨撪枌昦曄偺昦棟
擔杮晈恖壢昦棟妛夛帍丂2011;2(1):2-5.
彫捤桽巌
亂慜棫態娻(戞2斉)-婎慴丒椪彴尋媶偺傾僢僾僨乕僩-亃 婎慴丂慜棫態娻偺昦棟丂慜棫態昦棟偵偍偗傞柶塽愼怓偺桳梡惈
擔杮椪彴丂2011;69(憹姧5 慜棫態娻):41-44.
堦杮悪憦, 浟揘煫, 徏栘峃恀, 戝昹庻攷, 壀懞懽旻, 怷扟戩栫
擏夎庮惈擕態墛偺8椺
擔杮椪彴奜壢妛夛嶨帍丂2011;72(11):2776-2781.
尨揷戝, 搚壆崃堦, 廐嶳懢, 怷扟戩栫, 憹揷偟偺傇, 捗揷嬒, 杧堜棟奊, 慜揷堦榊, 嶳岥椣, 彫捤桽巌, 幁屢捈庽
亂擕態偺嵶朎恌偲恓惗専偺尰忬偲栤戣揰(2)亃 擕態恓惗専偵偍偗傞昦棟恌抐偺尰忬偲栤戣揰丂擕態恓惗専恌抐島廗夛偺寢壥偐傜
擕娻偺椪彴丂2011;26(2):161-174.
徏懞梼, 姍戧復墰, 愮梩妜, 惸摗寬巌, 尦揷晀峗, 妢堜孾擵, 孎扟堦峀, 崟悾尠, 敀愇懽嶰, 怷扟戩栫, 郪堜崅巙
擔杮偵偍偗傞僶乕僠儍儖僗儔僀僪傪棙梡偟偨僐儞僒儖僥乕僔儑儞僔僗僥儉偺奐敪
昦棟偲椪彴丂2011;29(9):1027-1032.
敥災丆暉壆旤撧巕丆幁屢捈庽
堛椕偵偍偗傞嵶朎恌偺栶妱
暉嶳堛妛丂2011;18:21-30.
Tanaka H, Sasayama T, Nishihara M, Arai A, Kawamura A, Kanomata N, Itoh T, Kohmura E.
Brain metastasis of undifferentiated sarcoma and response to temozolomide treatment. Case report.
Neurol Med Chir (Tokyo). 2010;50(8):689-693.
Sakai Y, Kanomata N, Itami H, Kajimoto K, Sakuma T, Ohbayashi C.
Signet-ring cell carcinoma of the stomach metastasizing to renal cell carcinoma: a case report and review of the literature.
Kobe J Med Sci. 2010;55(6):E122-131.
Hata S, Kanomata N, Kozuka Y, Fukuya M, Kobayashi TK, Ohno E, Moriya T.
Cytologic appearance of myospherulosis of the breast diagnosed by fine-needle aspirates: A clinical, cytological and immunocytochemical study of 23 cases.
Diagn Cytopathol. 2010;39(3):177-180.
Yamamoto S, Kasajima A, Takano M, Yaegashi N, Fujiwara H, Kuzuya K, Kigawa J, Tsuda H, Kurachi H, Kikuchi Y, Sugiyama T, Tsuda H, Moriya T.
Validation of the Histologic Grading for Ovarian Clear Cell Adenocarcinoma: A Retrospective Multi-institutional Study by the Japan Clear Cell Carcinoma Study Group.
Int. J. Gynecol. Pathol. 2010;30(2):129-138.
Nagaharu K, Zhang X, Yoshida T, Katoh D, Hanamura N, Kozuka Y, Ogawa T, Shiraishi T, Imanaka-Yoshida K.
Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells.
Am J Pathol. 2010;178(2):754-763.
Yoshinaga K, Ito K, Moriya T, Nagase S, Takano T, Niikura H, Sasano H, Yaegashi N, Sato Y.
Roles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas.
Cancer Sci. 2010;102(2):446-451.
Takano M, Sugiyama T, Yaegashi N, Sagae S, Kuzuya K, Udagawa Y, Tsuda H, Suzuki M, Kigawa J, Goto T, Tsuda H, Moriya T, Kikuchi Y.
Less Impact of Adjuvant Chemotherapy for Stage I Clear Cell Carcinoma of the Ovary: A Retrospective Japan Clear Cell Carcinoma Study.
Int. J. Gynecol. Cancer. 2010;20(9):1506-1510.
Nishi Y, Namikoshi T, Sasaki T, Tokura T, Nagasu H, Nakanishi H, Kozuka Y, Kashihara N.
Histopathological manifestations of membranoproliferative glomerulonephritis and glomerular expression of plasmalemmal vesicle-associated protein-1 in a patient with polycythemia vera.
Clin Nephrol. 2010;74(5):393-398.
Kurebayashi J, Kanomata N, Moriya T, Kozuka Y, Watanabe M, Sonoo H.
Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtype.
BMC cancer. 2010;20(10):568.
Toi M, Ohashi Y, Seow A, Moriya T, Tse G, Sasano H, Park BW, Chow LW, Laudico AV, Yip CH, Ueno E, Ishiguro H, Bando H.
The Breast Cancer Working Group presentation was divided into three sections: the epidemiology, pathology and treatment of breast cancer.
Jpn J Clin Oncol. 2010;40(Suppl1):13-18.
Umemura S, Kurosumi M, Moriya T, Oyama T, Arihiro K, Yamashita H, Umekita Y, Komoike Y, Shimizu C, Fukushima H, Kajiwara H, Akiyama F.
Recommendations for 'Adequate Evaluation of Hormone Receptors' A report of the task force of the Japanese Breast Cancer Society.
Oncol Rep. 2010;24(2):299-304.
Hata S, Kanomata N, Kozuka Y, Fukuya M, Ohno E, Moriya T.
Significance of collagenous and mucinous spherulosis in breast cytology specimens.
Cytopathology. 2010;21(3):157-160.
Suzuki T, Miki Y, Takagi K, Hirakawa H, Moriya T, Ohuchi N, Sasano H.
Androgens in human breast carcinoma.
Med Mol Morphol. 2010;43(2):75-81.
Moriya T, Kanomata N, Kozuka Y, Hirakawa H, Kimijima I, Kimura M, Watanabe M, Sasano H, Ishida T, Ohuchi N, Kurebayashi J, Sonoo H.
Molecular morphological approach to the pathological study of development and advancement of human breast cancer.
Med Mol Morphol. 2010;43(2):67-73.
Kawauchi S, Nawata H, Yamagata Y, Yaegashi H, Fukunaga M, Moriya T, Furuya T, Sugino N, Sasaki K.
Chromosomal imbalances detected by comparative genomic hybridization provide evidence that HMB-45-negative uterine angiomyolipomas belong to the PEComa family.
Histopathology. 2010;56(7):974-977.
Tamaki K, Sasano H, Maruo Y, Takahashi Y, Miyashita M, Moriya T, Sato Y, Hirakawa H, Tamaki N, Watanabe M, Ishida T, Ohuchi N.
Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast.
Cancer Sci. 2010 Feb 3;101(4):1051-1058.
Kasashima S, Ozaki S, Kawashima A, Zen Y, Moriya T, Inoue M.
Androgen receptor and 5alpha-reductase immunohistochemical profiles in extramammary Paget disease.
Br J Dermatol. 2010;162(5):1098-102.
Nakashima K, Kurebayashi J, Sonoo H, Tanaka K, Ikeda M, Shiiki S, Yamamoto Y, Nomura T, Sohda M, Seki M, Miyake A, Moriya T, Sadahira Y, Mimura H, Fukunaga M.
Preoperative dynamic lymphoscintigraphy predicts sentinel lymph node metastasis in patients with early breast cancer.
Breast Cancer. 2010;17(1):17-21.
怷扟戩栫, 拞搰堦婤
怹弫惈旝彫擕摢娻
専嵏偲媄弍 2010;38(4):291.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂旕怹弫惈擕娗娻(DCIS)偺昦棟妛揑垷暘椶偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
Cancer Board 擕娻 2010;3(1):52-53.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂僙儞僠僱儖儕儞僷愡偺専嶕朄丒昡壙朄偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
Cancer Board 擕娻 2010;3(1):54-55.
怷扟戩栫, SeowAdeline, TseGary
崙嵺揑側娤揰偐傜僩儕僾儖僱僈僥傿僽擕娻偲basal-like擕娻傪峫偊傞
Cancer Board 擕娻 2010;3(1):56-61.
怷扟戩栫
亂昦棟宍懺妛僉乕儚乕僪亃 彈惈惗怋婍丂孠幚條壔惗
昦棟偲椪彴 2010;28(椪憹):252-253.
怷扟戩栫
亂昦棟宍懺妛僉乕儚乕僪亃 擕態丂饪忬峔憿
昦棟偲椪彴 2010;28(椪憹):274-275.
怷扟戩栫, 拞懞怣旻, 鑓尨宐巕, 帥壀榓旤, 奆栘弮巕, 嶁杮桼旤, 抾懞桼晍崄, 屆愳揟巕, 恀撶崕屓, 恗壢岾巕, 怉栘岹柧
堛妛嫵堢攷暔娰偵偍偗傞僶乕僠儍儖僗儔僀僪棙梡偺堄媊丂堛妛攷暔娰偵偍偗傞僶乕僠儍儖僗儔僀僪
擔杮墦妘堛椕妛夛嶨帍 2010;6(1):34-37.
幁屢捈庽
亂恡丒斿擜婍娻丂婎慴丒椪彴尋媶偺傾僢僾僨乕僩亃 惛憙娻丂婎慴尋媶丂惛憙娻偺昦棟暘椶
擔杮椪彴 2010;68(憹姧崋4 恡丒斿擜婍娻):457-463.
幁屢捈庽, 拞懞棽暥, 怷扟戩栫
亂巕媨栩娻梊杊丂専恌偲梊杊儚僋僠儞傪傔偖偭偰亃 HPV姶愼偵傛偭偰敪惗偡傞巕媨栩娻埲奜偺幘姵
嶻晈恖壢偺幚嵺丂2010;59(4):575-581.
彫捤桽巌
亂昦棟宍懺妛僉乕儚乕僪亃 抝惈惗怋婍丂婎掙嵶朎
昦棟偲椪彴 2010;28(椪憹):240-241.
榓媣棙旻, 搉曈捈庽, 墍晹岹, 怷扟戩栫, 揷拞寬戝, 媑栰惓
挊柧側宍幙嵶朎暘壔偺偨傔宍幙嵶朎庮偲偺娪暿傪梫偟偨峛忬態MALT儕儞僷庮偺1椺
撪暘斿奜壢 2010;27(2):110-115.
懢揷堣巕, 媑壀曐, 怷扟戩栫
儗儃僲儖僎僗僩儗儖彊曻宆IUS(LNG-IUS)偵傛傞巕媨態嬝徢偺昦棟妛揑曄壔偵偮偄偰
擔杮僄儞僪儊僩儕僆乕僔僗妛夛夛帍 2010;31:217-221
杧壠塸擵, 彫椦怢嵠, 摗杮憇敧, 廫憅寬旻, 嬵堜懃晇, 崟悾峗巎, 媨壓廋峴, 幁屢捈庽, 廐嶳棽, 嵅乆栘娐, 攼尨捈庽
曅懁嫻悈挋棷傪擣傔偨堐帩摟愅姵幰偺1椺
椪彴摟愅 2010;26(8):1137-1144.
怷扟戩栫, 拞搰堦婤
擲塼娻
専嵏偲媄弍 2010;38(8):627.
怷扟戩栫
巕媨栩晹嵶朎恌偵偍偗傞怴曬崘條幃摫擖偺堄媊丂昦棟堛偺棫応偐傜
擔杮椪彴嵶朎妛夛嬨廈楢崌夛嶨帍 2010;41:9-14.
懢揷桾夘丆揷拞崕峗, 惸摗榠丆壓搊巙楴,嶳杮桾丆峠椦弤堦, 墍旜攷巌,幁屢捈庽丆怷扟戩栫
峛忬態尨敪恄宱撪暘斿娻乮彫嵶朎娻乯偺侾椺
撪暘斿奜壢 2010;27(3):208.
壓搊巙楴丆揷拞崕峗, 惸摗榠丆懢揷桾夘丆嶳杮桾丆峠椦弤堦, 幁屢捈庽丆墍旜攷巌
峛忬態傃傑傫惈峝壔宆擕摢娻偺侾椺
撪暘斿奜壢 2010;27(3):220-223.
塇尨棙岾,墍晹岹,奀尨嫳巕,摗懞婭峴,幊屗柧旤,敥災,怷扟戩栫,彫抮廏帰,婽堜晀徍,媑栰惓
奺庬幘姵孮偵弌尰偡傞暊峯撪斀墳惈拞旂偺嵶朎妛揑偍傛傃嵶朎宍懺寁應夝愅
擔杮椪彴嵶朎妛夛嶨帍 2010;49(5):330-336.
塇尨棙岾,墍晹岹,奀尨嫳巕,摗懞婭峴,幊屗柧旤,敥災,怷扟戩栫,彫抮廏帰,婽堜晀徍,媑栰惓
Collagenous stroma傪敽偆懡悢偺斀墳惈拞旂嵶朎廤夠偑弌尰偟偨暊悈嵶朎恌偺1椺
擔杮椪彴嵶朎妛夛嶨帍 2010;49(5):356-360.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂擕娻偺僌儗乕僪偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
Cancer Board 擕娻 2010;3(2):48-49.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂丂擕娻偵懳偡傞昦棟妛揑帯椕岠壥偺敾掕朄偵偮偄偰嫵偊偰偔偩偝偄(Q&A)
Cancer Board 擕娻 2010;3(1):50-51.
幁屢捈庽
恡憻tubulocystic carcinoma
昦棟偲椪彴 2010;28(10):1088.
墍旜攷巌丆怷扟戩栫
擔杮偺擕娻庢埖偄婯栺偲悽奅偺婯栺偲偺堘偄乕TNM暘椶丆慻怐妛揑暘椶丆RECIST傪拞怱偵乕
奜壢帯椕 2010;103(5):457-463.
椦嶈媊塮,戝媣曐桖堦,怷扟戩栫,塒堜惞懜,嫶扟揷恀庽,嫬弮,廙嶳崃恖
愭擖惈戙幱堎忢徢偑巰偺婡揮偵娭梌偟偨壜擻惈偑偁傞擕帣媫巰偺堦椺
朄堛妛偺幚嵺偲尋媶 2010;53:93-98.
戝媣曐桖堦,椦嶈媊塮,怷扟戩栫,廙嶳崃恖
嫬奅柧椖側昦曄傪掓偟偨怱嬝墛偺1椺
朄堛妛偺幚嵺偲尋媶 2010;53:87-91.
暉壆旤撧巕,敥災,鑓尨戱梇,彫椦攷媣,惉晉恀棟,崱栰榓帯,暷椇桽,峳栘朙巕,郷嶈廃師,掕暯媑搒,幁屢捈庽,怷扟戩栫
摉堾偵偍偗傞儀僙僗僟弨嫆巕媨栩晹嵶朎恌曬崘條幃(堛夛暘椶)摫擖慜屻偺斾妑専摙丂専懱晄揔惓丄堎宆滸暯忋旂嵶朎偵偮偄偰
擔杮椪彴嵶朎妛夛壀嶳巟晹夛帍 2010;29:17-19.
惉晉恀棟,敥災,暉壆旤撧巕,彫椦攷媣,鑓尨戱梇,幁屢捈庽
擜娗僇僥乕僥儖擜拞偵傒傜傟傞戝宆廤夠偍傛傃塓姫條峔憿偺専摙
擔杮椪彴嵶朎妛夛壀嶳巟晹夛帍 2010;29:24-26.
暷椇桽,暉壆旤撧巕,峳栘朙巕,惉晉恀棟,娾抦摴怢媣,鑓尨戱梇,敥災,埳釾岟,郷嶈廃師,掕暯媑搒,幁屢捈庽
廲妘撪堎強惈峛忬態庮4椺偺嵶朎妛揑専摙
擔杮椪彴嵶朎妛夛壀嶳巟晹夛帍 2010;29:29-30.
幁屢捈庽,彫捤桽巌,怷扟戩栫
HPV姶愼偵傛偭偰敪惗偡傞巕媨栩偑傫埲奜偺幘姵
壔妛椕朄偺椞堟 2010;27(2):58-63.
怷扟戩栫, 暯愳媣
態嬝忋旂庮
専嵏偲媄弍 2010;39(2):113.
Moriya T, Kanomata N, Kozuka Y, Fukumoto M, Iwachido N, Hata S, Takahashi Y, Miura H, Ishida K, Watanabe M
Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions.
Breast Cancer. 2009;16(3):173-8.
Takano M, Sugiyama T, Yaegashi N, Suzuki M, Tsuda H, Sagae S, Udagawa Y, Kuzuya K, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Kikuchi Y.
The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study.
International journal of gynecological cancer 2009;19(8):1353-1357.
Tse GM, Tan PH, Lau KM, de Andrade VP, Lui PC, Vong JS, Chaiwun B, Lam CC, Yu AM, Moriya T.
Breast cancer in the elderly: a histological assessment.
Histopathology. 2009;55(4):441-451.
Sakai J, Moriya T, Takahashi S, Hashiyada M, Funayama M.
An infantile case of asphyxia with coincidental myocarditis.
Legal medicine. 2009;11(6):291-293.
Gotoh H, Kanomata N, Yoshimura M, Ohno Y, Moriya T, Ohbayashi C.
Morphometric analysis of regional lymph nodes in surgically resected non-small cell lung cancer.
Med Mol Morphol. 2009;42(3):162-166.
Hosaka T, Kimura H, Heishi T, Suzuki Y, Miyashita H, Ohta H, Sonoda H, Moriya T, Suzuki S, Kondo T, Sato Y.
Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis.
Am J Pathol. 2009;175(1):430-439.
Tsuchiya S, Akiyama F, Moriya T, Tsuda H, Umemura S, Katayama Y, Ishihara A, Inai Y, Itoh H, Kitamura T.
A new reporting form for breast cytology.
Breast Cancer. 2009;16(3):202-6.
Nagaoka M, Nara M, Tamada T, Kume H, Oguma T, Kikuchi T, Zaini J, Moriya T, Ichinose M, Tamura G, Hattori T.
Regulation of adenosine 5'-triphosphate (ATP)-gated P2X(4) receptors on tracheal smooth muscle cells.
Respir Physiol Neurobiol. 2009;166(1):61-7.
Tabata T, Koduka Y, Yanoh K, Koduka YK, Murabayashi N, Shiraishi T, Sagawa N.
Fine needle aspiration cytology of malignant mixed tumour of the vulva.
Cytopathology. 2009;20(3):199-201.
Tse GM, Tan PH, Moriya T.
The role of immunohistochemistry in the differential diagnosis of papillary lesions of the breast.
J Clin Pathol. 2009;62(5):407-13.
Kanomata N.
Four-Leafed Clover.
Int J Surg Pathol. 2009;17(1):41.
Moriya T, Kozuka Y, Kanomata N, Tse GM, Tan PH.
The role of immunohistochemistry in the differential diagnosis of breast lesions.
Pathology. 2009;41(1):68-76.
摗懞婭峴丆墍晹岹丆奀尨嫵峜丆塇尨棙岾丆怷扟戩栫
懡悢偺妀撪嵶朎幙晻擖懱偑娤嶡偝傟偨擕態梓棻嵶朎庮偺侾椺
擔杮椪彴嵶朎妛夛嶨帍 2009;48(6):366-370.
敥災丆幁屢捈庽丆嶰忋朏婌丆怷扟戩栫
嵶朎恌昗杮傪梡偄偨柶塽嵶朎壔妛傊偺墳梡
昦棟偲椪彴 2009;27(12):1197-1206.
戝嫶梞堦, 搚揷寷, 烴堜捈, 嵅摗攷巕, 埨揷岾帯, 奓塇媊峗, 嵅摗奭, 嶳岥惓柧, 怷扟戩栫
G-CSF嶻惗廫擇巜挵尨敪墛徢惈埆惈慄堐惈慻怐媴庮偺1庤弍椺
擔杮徚壔婍奜壢妛夛嶨帍 2009;42(11):1676-1681.
彫捤桽巌, 幁屢捈庽, 怷扟戩栫
亂僲儌僌儔儉帪戙偺慜棫態昦棟亃 慜棫態昦棟偵偍偗傞柶塽愼怓偺桳梡惈偲拲堄揰
昦棟偲椪彴 2009;27(10):971-977.
怷扟戩栫, 拞搰堦婤
擕態慄堐態庮
専嵏偲媄弍 2009;37(11):1280.
嶰塝峅庣, 埨払桭捗, 埨揷撧捗巕, 搉曈傒偐, 愇揷榓擵, 姟扟壝擵, 嶚栰岞怢, 怷扟戩栫
亂嵶朎恌偼偳偙傑偱拞旂庮偵敆傟傞偐亃 懱峯塼傪梡偄偨埆惈拞旂庮偺嵶朎恌抐丂敾掕傪崲擄偵偡傞梫場偲嵶朎宍懺偐傜傒偨斀墳惈拞旂偲偺娪暿
擔杮椪彴嵶朎妛夛嶨帍 2009;48(5):319-326.
敥災, 怷扟戩栫, 娾抦摴怢媣, 婽堜晀徍
亂嵶朎恌偼偳偙傑偱拞旂庮偵敆傟傞偐亃 懱峯塼嵶朎恌偵偍偗傞collagenous stroma傪桳偡傞嵶朎廤夠偵偮偄偰丂宍懺妛揑摿挜偲偦偺椪彴昦棟妛揑堄媊
擔杮椪彴嵶朎妛夛嶨帍 2009;48(5):312-318.
壴懞揟巕, 彫愳朁巕, 嶳壓夒巕, 嶰堜婱巕, 攼憅桼旤, 挘怱宒, 彫捤桽巌, 敀愇懽嶰
擕態朼悗嵶朎娻偺1椺
擕娻偺椪彴 2009;24(4):537-540.
怷扟戩栫, 拞搰堦婤
怹弫惈擕娗娻,廩幚態娗娻
専嵏偲媄弍 2009;37(7):637.
怷扟戩栫丆拞搰堦婤
怹弫惈擕娗娻丆峝娻
専嵏偲媄弍 2009;37(4):346.
嬤摗晲巎, 幁屢捈庽, 擔岦怣擵
銷泖暻傾儈儘僀僪庮釃偺1椺
撪壢 2009;103(4):764.
搉曈捈庽,戝懡榓懽岾,墍晹岹丆怷扟戩栫
梀棧暊晹帀朾恀旂曎堏怉朄偺専摙
擕娻偺椪彴 2009;24(2):193-199.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂 昦棟昗杮偺屌掕朄偺僐僣偵偮偄偰嫵偊偰壓偝偄
Cancer Board 擕娻 2009;2(2):38-39.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂 壏懚庤弍偵偍偗傞愗彍抐抂偺昡壙朄偵偮偄偰嫵偊偰壓偝偄
Cancer Board 擕娻 2009;2(2):36-37.
怷扟戩栫, 暉杮婎
亂昦棟妛偲幮夛亃 幮夛栤戣偲側偭偨幘姵偲昦棟妛亙偑傫亜擕娻
昦棟偲椪彴 2009;27(椪帪憹姧崋):224-229.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂 HER2夁忚敪尰偺専嶕朄偲敾掕婎弨偵偮偄偰嫵偊偰偔偩偝偄
Cancer Board 擕娻 2009;2(1):42.
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂 僩儕僾儖僱僈僥傿僽擕娻偵偮偄偰嫵偊偰偔偩偝偄
Cancer Board 擕娻 2009;2(1):43.
Takano M, Sugiyama T, Yaegashi N, Sakuma M, Suzuki M, Saga Y, Kuzuya K, Kigawa J, Shimada M, Tsuda H, Moriya T, Yoshizaki A, Kita T, Kikuchi Y.
Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study.
Int J Gynecol Cancer. 2008;18(5):937-42.
Tamaki K, Moriya T, Sato Y, Ishida T, Maruo Y, Yoshinaga K, Ohuchi N, Sasano H.
Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis.
Cancer Sci. 2009;100(1):88-94.
Harada-Shoji N, Yamada T, Ishida T, Amari M, Suzuki A, Moriya T, Ohuchi N.
Usefulness of lesion image mapping with multidetector-row helical computed tomography using a dedicated skin marker in breast-conserving surgery.
Eur Radiol. 2008;19(4):868-874.
Ishida M, Egawa S, Kawaguchi K, Aoki T, Sakata N, Mikami Y, Motoi F, Abe T,
Fukuyama S, Katayose Y, Sunamura M, Unno M, Moriya T, Horii A, Furukawa T.
Synchronous and metachronous extrapancreatic malignant neoplasms in patients with intraductal papillary-mucinous neoplasm of the pancreas.
Pancreatology. 2008;8(6):577-82.
Suzuki N, Katsusihma H, Takeuchi K, Nakamura S, Ishizawa K, Ishii S, Moriya T,
DeCoteau JF, Miura I, Ichinohasama R.
Cytogenetic abnormality 46,XX,add(21)(q11.2) in a patient with follicular
dendritic cell sarcoma.
Cancer Genet Cytogenet. 2008;186(1):54-7.
Tanaka T, Sato H, Tada A, Moriya T, Wada Y, Nishida K.
Case of orbital sebaceous carcinoma developing twenty-seven years after
enucleation.
Jpn J Ophthalmol. 2008;52(4):344-5.
Tse GM, Somali A, Chan AW, Chaiwun B, Lui PC, Moriya T, Hwang JS, Chan NH, Tan PH.
Fine needle aspiration cytology of breast cancer in women aged 70 years and older.
Pathology. 2008;40(6):573-9.
Sasajima Y, Mikami Y, Kaku T, Kiyokawa T, Ohishi Y, Hamada T, Sasaki T, Fujita H, Moriya T, Kasamatsu T, Tsuda H.
Gross features of lobular endocervical glandular hyperplasia in comparison with
minimal-deviation adenocarcinoma and stage Ib endocervical-type mucinous
adenocarcinoma of the uterine cervix.
Histopathology. 2008;53(4):487-90.
Takami K, Miura K, Takeuchi H, Egawa S, Moriya T, Nakamura Y, Tanabe A, Sugita J, Karasawa H, Unno M, Sasaki I.
Granulocyte-colony stimulating factor-producing pancreatic cancer: report of a
case.
Surg Today. 2008;38(5):453-7.
Chen MH, Wai-Cheong Yip G, Tse GM, Moriya T, Lui PC, Zin ML, Bay BH, Tan PH.
Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters.
Mod Pathol. 2008;21(10):1183-91.
Suzuki T, Miki Y, Akahira JI, Moriya T, Ohuchi N, Sasano H.
Aromatase in Human Breast Carcinoma as a Key Regulator of Intratumoral Sex Steroid Concentrations.
Endocr J. 2008;55(3):455-63.
Takahashi S, Kanetake J, Moriya T, Funayama M.
Sudden infant death from dilated cardiomyopathy with endocardial fibroelastosis.
Leg Med (Tokyo). 2008;10(5):277-80.
Norimatsu Y, Miyamoto M, Kobayashi TK, Moriya T, Shimizu K, Yanoh K, Tsukayama C, Miyake Y, Ohno E.
Diagnostic utility of phosphatase and tensin homolog, beta-catenin, and p53 for endometrial carcinoma by thin-layer endometrial preparations.
Cancer (Cancer Cytopathol). 2008;114(3):155-64.
Tanaka T, Okanobu H, Yoshimi S, Murakami E, Kogame A, Imagawa H, Numata Y, Kuga Y, Moriya T, Ohya T, Kajiyama G.
In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naive patients.
Dig Liver Dis. 2008;40(9):731-6.
Norimatsu Y, Miyamoto T, Kobayashi TK, Oda T, Moriya T, Yanoh K, Miyake Y, Ohno E.
Utility of thin-layer preparations in endometrial cytology: immunocytochemical expression of PTEN, beta-catenin and p53 for benign endometrial lesions.
Diagn Cytopathol. 2008;36(4):216-23.
Norimatsu Y, Kouda H, Kobayashi TK, Moriya T, Yanoh K, Tsukayama C, Miyake Y, Ohno E.
Utility of thin-layer preparations in the endometrial cytology: evaluation of benign endometrial lesions.
Ann Diagn Pathol. 2008;12(2):103-11.
Yoshinaga K, Ito K, Moriya T, Nagase S, Takano T, Niikura H, Yaegashi N, Sato Y.
Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer.
Cancer Sci. 2008;99(5):914-9.
Shibuya R, Suzuki T, Miki Y, Yoshida K, Moriya T, Ono K, Akahira J, Ishida T, Hirakawa H, Evans DB, Sasano H.
Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast.
Endocr Relat Cancer. 2008;15(1):113-24.
Sasano H, Suzuki T, Miki Y, Moriya T.
Intracrinology of estrogens and androgens in breast carcinoma.
J Steroid Biochem Mol Biol. 2008;108:181-5.
Honda J, Sasa M, Moriya T, Bando Y, Hirose T, Takahashi M, Nagao T, Tangoku A.
Thymidine phosphorylase and dihydropyrimidine dehydrogenase are predictive factors of therapeutic efficacy of capecitabine monotherapy for breast cancer-preliminary results.
J Med Invest. 2008;55(1-2):54-60.
Ishida T, Takeda M, Suzuki A, Amari M, Moriya T, Ohuchi N.
Significance of irradiation in breast-conserving treatment: comparison of local recurrence rates in irradiated and nonirradiated groups.
Int J Clin Oncol. 2008;13(1):12-7.
Takahashi S, Moriya T, Ishida T, Shibata H, Sasano H, Ohuchi N, Ishioka C.
Prediction of breast cancer prognosis by gene expression profile of TP53 status.
Cancer Sci. 2008;99(2):324-32.
Miura K, Kobayashi T, Funayama Y, Fukushima K, Ogawa H, Oyama A, Itoh A, Moriya T, Yamada T, Okumoto T, Shibata C, Sasaki I.
Giant T4 rectal carcinoma mimicking urinary bladder adenocarcinoma accurately diagnosed by immunohistochemistry and successfully treated with total pelvic exenteration: report of a case.
Surg Today. 2008;38(3):261-5.
Terakawa T, Miyake H, Kanomata N, Kumano M, Takenaka A, Fujisawao M.
Inverse association between histologic inflammation in needle biopsy specimens
and prostate cancer in men with serum PSA of 10-50 ng/mL.
Urology. 2008;72(6):1194-7.
Sasayama T, Nishihara M, Tanaka K, Mizukawa K, Ehara K, Kanomata N, Kohmura E.
Two metachronous tumors induced by radiation therapy: case report and review of the literature.
J Neurooncol. 2008;88(3):315-20.
幁屢捈庽, 怷扟戩栫
恓惗専偵傛傞擕態偺旕怹弫惈擕娗娻偺昦棟恌抐
捁庢椪彴壢妛 2008;1(2) 374-379.
戝搰悙曐, 怴憅恗, 搉曈傒偐, 嵅摗攷, 怷扟戩栫
巕媨栩晹態宯庮釃偵偍偗傞KL-6敪尰丗柶塽慻怐妛揑専摙
捁庢椪彴壢妛 2008;1(1) 190-195.
怷扟戩栫
擕態幘姵偺娪暿恌抐偵偍偗傞柶塽慻怐愼怓偺桳梡惈
Medical Technology 2008;36(12)1250-1252.
幁屢捈庽丆怷扟戩栫
恓惗専偵偍偗傞DCIS偺昦棟慻怐恌抐丗恌抐偺梫揰偲尷奅
擕娻偺椪彴 2008;23(6) 495-501
怷扟戩栫
擕娗撪昦曄偺椙丒埆惈娪暿恌抐乕掅擕摢忬峔憿乣暯扲宆昦曄偺娪暿揰偵偮偄偰乕
擕娻偺椪彴 2008;23(6) 525-530
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂 儂儖儌儞庴梕懱敪尰偺敾掕婎弨偵偮偄偰嫵偊偰偔偩偝偄
Cancer Board 擕娻 2008;1(1):24
怷扟戩栫
傛偔傢偐傞昦棟恌抐曬崘彂 嵶朎恌丒恓惗専偺曬崘條幃偵偮偄偰嫵偊偰偔偩偝偄
Cancer Board 擕娻 2008;1(1):23
彫捤桽巌, 幁屢捈庽, 怷扟戩栫
Rosen triad
昦棟偲椪彴 2008;26(11):1210-1211
怷扟戩栫, 彫捤桽巌, 幁屢捈庽
亂擕娻丂慻怐宆恌抐偺僐僣亃 娪暿恌抐偺僐僣丂擕娗撪擕摢庮vs旕怹弫惈擕娗娻(擕摢娻)
昦棟偲椪彴 2008;26(11):1189-1191
彫捤桽巌, 幁屢捈庽, 怷扟戩栫
亂擕娻丂慻怐宆恌抐偺僐僣亃 偍偝偊偰偍偒偨偄慻怐宆丂峝壔惈態徢撪旕怹弫惈擕娗娻
昦棟偲椪彴 2008;26(11) 1145-1147
怷扟戩栫, 幁屢捈庽
亂擕娻丂擕態昦棟恌抐偺幚嵺亃 慻怐宆暘椶偺夝愢丂WHO
昦棟偲椪彴 2008;26(10) 1029-1033
惔悈宐巕, 懃徏椙柧, 彫柛惞巕, 嶗堜岶婯, 怷扟戩栫, 嶗堜姴屓
亂巕媨撪枌嵶朎恌偵偍偗傞恌抐惛搙岦忋傊偺怴偟偄挧愴亃 撪枌嵶朎恌媈梲惈椺偺専摙丂峔憿堎宆傪壛枴偟偨怴敾掕婎弨偺専摙
擔杮椪彴嵶朎妛夛嶨帍 2008;47(3):249-254
懃徏椙柧, 惔悈宐巕, 崄揷峗旤, 尨揷旤崄, 妬扟攷懃, 怷扟戩栫, 榓恗梞帯, 戝栰塸帯
亂巕媨撪枌嵶朎恌偵偍偗傞恌抐惛搙岦忋傊偺怴偟偄挧愴亃 Endometrial glandular and stromal breakdown偺専摙丂壔惗偺嵶朎妛揑摿挜
擔杮椪彴嵶朎妛夛嶨帍 2008;47(3):243-248
怷扟戩栫, 彫捤桽巌, 敥災
亂奜壢昦棟儅僯儏傾儖亃 憤榑丂嵶朎恌暪梡偺堄媊
昦棟偲椪彴 2008;26(椪憹):74-80
怷扟戩栫, 彫捤桽巌, 幁屢捈庽
巕媨偺昦棟嘦乕巕媨懱晹乕 椶撪枌態娻丂乕慻怐妛揑僗儁僋僩儔儉乕
昦棟偲椪彴 2008;26(4):352-359
敥災, 怷扟戩栫
栶棫偮専嵏僨乕僞傪摼傞偨傔偺僒儞僾儕儞僌丂惓妋側昦棟丒嵶朎恌抐傪摼傞偨傔偺専嵏慜夁岆(僾儗傾僫儕僥傿僇儖僄儔乕)偺杊巭偵娭偟偰
椪彴昦棟 2008;56(3):228-238
旘徏悞巕, 妬攷巎, 堜忋婌暥, 撪摗弮巕, 梋旤宒, 嶳撪旤崄, 幁屢捈庽, 媨撪復岝, 崱惣峃梇, 悪杮棙巏, 愮尨榓晇
妶惈宆價僞儈儞D崅抣偑慗墑偟偨暃旲峯庮釃偵傛傞庮釃惈掅儕儞寣徢惈崪擃壔徢偺堦椺
儂儖儌儞偲椪彴 2008;56(弔婫憹姧): 172-177
敥災, 嶰忋朏婌, 怷扟戩栫
亂巕媨偺昦棟丂巕媨栩晹亃 巕媨栩晹偺嵶朎恌
昦棟偲椪彴 2008;26(3):237-244
怷扟戩栫
擕娻庤弍椺偺儕僗僋僇僥僑儕乕丂St.Gallen 2007僐儞僙儞僒僗夛媍偐傜
昦棟偲椪彴 2008;26(2):178-179
崅尒堦峅, 嶰塝峃, 彫椦徠拤, 怷扟戩栫, 幠揷嬤, 栘撪惤, 彫嶳弤, 戝徖擡, 嵅乆栘岹擵, 嵅乆栘娹
徻嵶側昦棟慻怐妛揑専摙偵傛傝恌抐偝傟偨堓枹暘壔娻偺1椺
擔杮徚壔婍奜壢妛夛嶨帍 2008;41(1):52-56
懃徏椙柧, 惔悈宐巕, 崄揷峗旤, 尨揷旤崄, 妬扟攷懃, 怷扟戩栫, 榓恗梞帯, 戝栰塸帯
Endometrial glandular and stromal breakdown偺専摙乕壔惗偺嵶朎妛揑摿挜乕
擔杮椪彴嵶朎妛夛嶨帍 2008;47(3):243-248
惔悈宐巕, 懃徏椙柧, 彫柛惞巕, 嶗堜岶婯, 怷扟戩栫, 嶗堜姴屓
撪枌嵶朎恌媈梲惈椺偺専摙乕峔憿堎宆傪壛枴偟偨怴敾掕婎弨偺専摙乕
擔杮椪彴嵶朎妛夛嶨帍 2008;47(3):249-254
扟懞晲岹, 抾壴嫵, 墦摗媊梞, 杒懞摴旻, 敧廳妦峅, 怷扟戩栫
DCIS in sclerosing adenosis偺1椺
搶杒堛妛嶨帍 2008;120(1):143-144
拞懞抦庽, 徏曱徍旻, 拞嬻斏搊, 擁嶈崕擵, 撪揷弤惓, 惣懞孾夘, 彫捤桽巌, 崱堜桾, 敀愇懽嶰, 慜揷惓岾, 懡忋抭峃, 壛摗桾栫, 懞揷揘栫
戝戁崪擃庮釃偺1椺
搶奀崪擃晹庮釃 2008;20:9-10
Suzuki T, Miki Y, Moriya T, Akahira J, Ishida T, Hirakawa H, Yamaguchi Y, Hayashi S, Sasano H.
5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production.
Int J Cancer. 2007;120(2):285-91.
Sakuma M, Akahira J, Ito K, Niikura H, Moriya T, Okamura K, Sasano H, Yaegashi N.
Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer.
Cancer Sci. 2007;98(3):380-6.
Arihiro K, Umemura S, Kurosumi M, Moriya T, Oyama T, Yamashita H, Umekita Y, Komoike Y, Shimizu C, Fukushima H, Kajiwara H, Akiyama F.
Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays.
Am J Clin Pathol. 2007;127(3):356-65.
Norimatsu Y, Moriya T, Kobayashi TK, Sakurai T, Shimizu K, Tsukayama C, Ohno E.
Immunohistochemical expression of PTEN and beta-catenin for endometrial intraepithelial neoplasia in Japanese women.
Ann Diagn Pathol. 2007;11(2):103-8.
Suzuki T, Urano T, Miki Y, Moriya T, Akahira J, Ishida T, Horie K, Inoue S, Sasano H.
Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor.
Cancer Sci. 2007;98(5):644-51.
Kudoh K, Shibata C, Funayama Y, Fukushima K, Takahashi K, Ogawa H, Sagami Y, Hirabayashi Y, Moriya T, Sasaki I.
Gastrojejunostomy and duodenojejunostomy for megaduodenum in systemic sclerosis sine scleroderma: report of a case.
Dig Dis Sci. 2007;52(9):2257-60.
Miki Y, Suzuki T, Tazawa C, Yamaguchi Y, Kitada K, Honma S, Moriya T, Hirakawa H, Evans DB, Hayashi S, Ohuchi N, Sasano H.
Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
Cancer Res. 2007;67(8):3945-54.
Usami S, Moriya T, Amari M, Suzuki A, Ishida T, Sasano H, Ohuchi N.
Reliability of prognostic factors in breast carcinoma determined by core needle biopsy.
Jpn J Clin Oncol. 2007;37(4):250-5.
Tokunaga H, Akahira J, Suzuki T, Moriya T, Sasano H, Ito K, Yaegashi N.
Ovarian epithelial carcinoma with estrogen-producing stroma.
Pathol Int. 2007;57(5):285-90.
Saito S, Murakami T, Suzuki K, Terada Y, Fukushima K, Moriya T.
Intestinal endometriosis complicated by ileal perforation after initiation of gonadotropin-releasing hormone agonist therapy.
Fertil Steril. 2007;88(4):969.e7-9.
Ishii T, Kohu K, Yamada S, Ishidoya S, Kanto S, Fuji H, Moriya T, Satake M, Arai Y.
Up-regulation of DNA-methyltransferase 3A expression is associated with hypomethylation of intron 25 in human testicular germ cell tumors.
Tohoku J Exp Med. 2007;212(2):177-90.
Ota K, Ito K, Akahira J, Sato N, Onogawa T, Moriya T, Unno M, Abe T, Niikura H, Takano T, Yaegashi N.
Expression of organic cation transporter SLC22A16 in human epithelial ovarian cancer: a possible role of the adriamycin importer.
Int J Gynecol Pathol. 2007;26(3):334-40.
Suzuki T, Inoue A, Miki Y, Moriya T, Akahira J, Ishida T, Hirakawa H, Yamaguchi Y, Hayashi S, Sasano H.
Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor.
Endocr Relat Cancer. 2007;14(2):279-92.
Oka K, Sando N, Moriya T, Yatabe Y.
Malignant adenomyoepithelioma of the breast with matrix production may be compatible with one variant form of matrix-producing carcinoma: A case report.
Pathol Res Pract. 2007;203(8):599-604.
Matsushita M, Ito A, Ishidoya S, Endoh M, Moriya T, Arai Y.
Intravenous extended liposarcoma arising from renal sinus.
Int J Urol. 2007;14(8):769-70.
Takano M, Sugiyama T, Yaegashi N, Suzuki M, Tsuda H, Sagae S, Udagawa Y, Kuzuya K, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Kikuchi Y.
Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis.
Int J Clin Oncol. 2007;12(4):256-60.
Kurebayashi J, Moriya T, Ishida T, Hirakawa H, Kurosumi M, Akiyama F, Kinoshita T, Takei H, Takahashi K, Ikeda M, Nakashima K.
The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races.
Breast. 2007;16 Suppl 2:S72-7.
Yoshioka I, Saiki Y, Sakuma K, Iguchi A, Moriya T, Ikada Y, Tabayashi K.
Bioabsorbable gelatin sheets latticed with polyglycolic acid can eliminate pericardial adhesion.
Ann Thorac Surg. 2007;84(3):864-70.
Suzuki T, Miki Y, Moriya T, Akahira J, Hirakawa H, Ohuchi N, Sasano H.
In situ production of sex steroids in human breast carcinoma.
Med Mol Morphol. 2007;40(3):121-7.
Sasano H, Suzuki T, Moriya T.
Analysis of surrogate markers for target-specific therapy in breast carcinomas using archival materials.
Biomed Pharmacother. 2007;61(9):543-7.
Ito M, Moriya T, Ishida T, Usami S, Kasajima A, Sasano H, Ohuchi N.
Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer.
Breast Cancer. 2007;14(4):381-7.
Usami O, Nara M, Tamada T, Kitamuro T, Tomaki M, Ashino Y, Onodera K, Miyazaki S, Moriya T, Hattori T.
Systemic sarcoidosis associated with double cancers of the esophagus and stomach.
Intern Med. 2007;46(24):2019-22.
Ishida M, Egawa S, Aoki T, Sakata N, Mikami Y, Motoi F, Abe T, Fukuyama
S, Sunamura M, Unno M, Moriya T, Horii A, Furukawa T.
Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
Pancreas. 2007;35(4):348-52.
Satoh M, Wang H, Ishidoya S, Abe H, Moriya T, Hamada H, Arai Y.
Oncolytic virotherapy for prostate cancer by E1A, E1B mutant adenovirus.
Urology. 2007;70(6):1243-8.
Hara I, Kawabata G, Tanaka K, Kanomata N, Miyake H, Takenaka A, Fujisawa M.
Oncological outcome of laparoscopic prostatectomy.
Int J Urol. 2007;14(6):515-20.
Suzuki C, Maeda M, Hori K, Kozuka Y, Sakuma H, Taki W, Takeda K.
Apparent diffusion coefficient of pituitary macroadenoma evaluated with line-scan diffusion-weighted imaging.
J Neuroradiol. 2007;34(4):228-35.
Hirokawa YS, Takagi A, Uchida K, Kozuka Y, Yoneda M, Watanabe M, Shiraishi T.
High level expression of STAG1/PMEPA1 in an androgen-independent prostate cancer PC3 subclone.
Cell Mol Biol Lett. 2007;12(3):370-7.
Murata K, Inoue H, Kozuka Y.
Gastric metastases from anaplastic pancreatic cancer.
Clin Gastroenterol Hepatol. 2007;5(1):e3.
彫捤桽巌, 崱堜桾, 撪揷崕揟, 峀愳壚巎, 敀愇懽嶰
亂慜棫態娻丂婎慴丒椪彴尋媶偺傾僢僾僨乕僩亃 婎慴尋媶丂昦棟丂Gleason score偺彅栤戣
擔杮椪彴 2007;65(擔杮椪彴):24-29
廐曐怣旻, 墦摗婓擵, 堜戲楬悽, 孎扟彑惌, 挿搱恀婭, 晲嶳弤擇, 敧廳妦峅, 搉曈傒偐, 怷扟戩栫
擕態慂巋媧堷嵶朎恌15470椺偺嵞専摙丂怴曬崘條幃摫擖偵傛傞曄壔
擔杮椪彴嵶朎妛夛嶨帍 2007;46(6):323-331
怷扟戩栫, 搉曈傒偐, 嶚栰岞怢
亂巕媨撪枌徢偺摿庩昦懺傪昦棟偲椪彴偐傜峫偊傞亃 昦棟偐傜丂巕媨撪枌徢偲棏憙娻
嶻晈恖壢偺幚嵺 2007;56(10):1443-1449
桍堜峀擵, 怷扟嫳巕, 戝怷徆巕, 巗懞峗堦, 摗懞婭峴, 塇尨棙岾, 孂揷偁偗傒, 怷扟戩栫, 墍晹岹, 媑栰惓
僨僕僞儖儅僀僋儘僗僐乕僾傪梡偄偨墦妘恦懍昦棟恌抐
擔杮墦妘堛椕妛夛嶨帍 2007;3(2):270-271
朷寧惷巬, 愇揷榓擵, 怷扟戩栫, 抌栬岝巌, 挿徖淎, 惸摗嫪梇, 嶚栰岞怢
巐巁壔僆僗儈僂儉傪梡偄偨僷儔僼傿儞曪杽愗曅偺帀朾愼怓朄
Therapeutic Research 2007;28(10):1938-1940
徏搰怣壚, 慜揷惓岾, 崅懞岝岾, 彫捤桽巌, 搾揷岤巌, 嶁堜揷杻桽巕, 楅栘愮怐, 抾揷姲
彫帣栩晹帀朾夎庮偺1椺丂MRI偲昦棟偺懳斾
椪彴曻幩慄 2007;52(10):1253-1256
怷扟戩栫, 揷懞惞寧, 彅尨崃旤, 埨払桭捗, 崱栰偐偍傝, 嬥栰惞, 嶰塝峅庣, 廐曐怣旻
亂擲塼惈攚宨傪敽偆奺壢椞堟偺庮釃亃 擲塼惈攚宨傪桳偡傞擕態幘姵偺慂巋媧堷嵶朎憸
擔杮椪彴嵶朎妛夛嶨帍 2007;46(5):287-291
恄嶳撃巎, 幠揷嬤, 廙嶳桾巑, 暉搰峗暯, 崅嫶尗堦, 忋栰払栫, 彫椦徠拤, 栘撪惤, 嵅乆栘涇, 怷扟戩栫
彫栐尨敪偲峫偊傜傟偨僈僗僩儕僲乕儅偺1椺
擔杮徚壔婍奜壢妛夛嶨帍 2007;40(9):1582-1586
枒愳杛巕, 恴朘棦旤, 嵅摗岾巕, 徏塝桼旤巕, 怺悾恀擵, 撪儢嶈怴栫, 怷扟戩栫
擕態態嬝忋旂庮丄朼悗嵶朎宆(adenomyoepithelioma,spindle cell type)偺1椺
擔杮椪彴嵶朎妛夛嶨帍 2007;46(4):216-221
怷扟戩栫
巹偺堦悇偟柶塽愼怓丂擕娗撪娻偺妋掕恌抐偺偨傔偵恄宱撪暘斿儅乕僇乕偑桳岠
専嵏偲媄弍 2007;35(6):554-555
怷扟戩栫, 塅嵅旤怢, 愇揷榓擵, 姟扟壝擵, 搉曈傒偐
亂擕娻丂婎慴丒椪彴尋媶偺傾僢僾僨乕僩亃 椪彴尋媶丂恌抐丂昦棟恌抐丂宱旂揑恓惗専朄
擔杮椪彴 2007;65(憹姧6 擕娻):261-264
怺挰壚悽巕, 愇揷岶愰, 晲揷尦攷, 娒棙惓榓, 楅栘徍旻, 塅嵅旤怢, 烴堜梀, 搉晹崉, 彫媨桾暥, 嬍忛寬懢榊, 戝撪寷柧, 怷扟戩栫
愇奃壔偺傒傪強尒偲偡傞旕怗抦擕娻傊偺懳墳
搶杒堛妛嶨帍 2007;119(1):111-112
楅栘婱, 怷扟戩栫, 嶚栰岞怢
亂擕娻丂婎慴丒椪彴尋媶偺傾僢僾僨乕僩亃 婎慴尋媶丂嵟嬤偺抦尒丂擕娻偵偍偗傞傾儘儅僞乕僛尋媶
擔杮椪彴 2007;65(憹姧6 擕娻):106-110
塇尨棙岾, 怷扟戩栫, 怷扟嫳巕, 摗懞婭峴, 戝懡榓懽岾, 搉曈捈庽, 彫抮廏帰, 愒栘拤岤
擕態婎幙嶻惗娻偺1椺
擕娻偺椪彴 2007;22(2):140-144
塅嵅旤怢 愇揷岶愰, 怺挰壚悽巕, 怷扟戩栫, 戝撪寷柧
亂庮釃偺弍慜丒弍拞恌抐偲弍幃慖戰亃 擕娻偺弍拞恌抐偲弍幃慖戰
奜壢 2007;69(2):200-204